<author><surname>Feshchenko</surname> <given-names>YuI</given-names></author> <author><surname>Melnyk</surname> <given-names>VM</given-names></author> <author><surname>Novozhilova</surname> <given-names>IO</given-names></author> <author><surname>Lyrnyk</surname> <given-names>SV</given-names></author> <title>The mortality of patients with tuberculosis: structure, dynamics and peculiarities in epidemic period</title> <source>Ukr Pulmonol J</source> <year>2009</year> <volume>3</volume> <fpage>5</fpage> - <lpage>9</lpage>
<author><surname>Nikolayevskyy</surname> <given-names>VV</given-names></author> <author><surname>Brown</surname> <given-names>TJ</given-names></author> <author><surname>Bazhora</surname> <given-names>YI</given-names></author> <author><surname>Asmolov</surname> <given-names>AA</given-names></author> <author><surname>Balabanova</surname> <given-names>YM</given-names></author> <author><surname>Drobniewski</surname> <given-names>FA</given-names></author> <title>Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine</title> <source>Clin Microbiol Infect</source> <year>2007</year> <volume>13</volume> <fpage>129</fpage> - <lpage>138</lpage>
<author><surname>Atun</surname> <given-names>R</given-names></author> <author><surname>Olynik</surname> <given-names>I</given-names></author> <title>Resistance to implementing policy change: the case of Ukraine</title> <source>Bulletin of World Health Organization</source> <year>2008</year> <volume>86</volume> <fpage>147</fpage> - <lpage>154</lpage>
<author><surname>Batdelger</surname> <given-names>D</given-names></author> <author><surname>Dandii</surname> <given-names>D</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Open label trial of therapeutic hepatitis B vaccine V-5 Immunitor (V5) delivered by oral route</title> <source>Lett Drug Design Discovery</source> <year>2007</year> <volume>4</volume> <fpage>540</fpage> - <lpage>544</lpage>
<author><surname>Batdelger</surname> <given-names>D</given-names></author> <author><surname>Dandii</surname> <given-names>D</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Open label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis</title> <source>C Vaccine</source> <year>2008</year> <volume>26</volume> <fpage>2733</fpage> - <lpage>2737</lpage>
<author><surname>Batdelger</surname> <given-names>D</given-names></author> <author><surname>Dandii</surname> <given-names>D</given-names></author> <author><surname>Dahgwahdorj</surname> <given-names>Ya</given-names></author> <author><surname>Erdenetsogt</surname> <given-names>E</given-names></author> <author><surname>Oyunbileg</surname> <given-names>J</given-names></author> <author><surname>Tsend</surname> <given-names>N</given-names></author> <author><surname>Bayarmagnai</surname> <given-names>B</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Clinical experience with therapeutic vaccines designed for patients with hepatitis</title> <source>Curr Pharm Design</source> <year>2009</year> <volume>15</volume> <fpage>1159</fpage> - <lpage>1171</lpage>
<author><surname>Arjanova</surname> <given-names>OV</given-names></author> <author><surname>Prihoda</surname> <given-names>ND</given-names></author> <author><surname>Yurchenko</surname> <given-names>LV</given-names></author> <author><surname>Sokolenko</surname> <given-names>NI</given-names></author> <author><surname>Frolov</surname> <given-names>VM</given-names></author> <author><surname>Tarakanovskaya</surname> <given-names>MG</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Phase 2 trial of V-5 Immunitor (V5) in patients with chronic hepatitis C co-infected with HIV and Mycobacterium tuberculosis</title> <source>J Vaccin Vaccinat</source> <year>2010</year> <volume>1</volume> <fpage>103</fpage>
<author><surname>Arjanova</surname> <given-names>OV</given-names></author> <author><surname>Prihoda</surname> <given-names>ND</given-names></author> <author><surname>Yurchenko</surname> <given-names>LV</given-names></author> <author><surname>Sokolenko</surname> <given-names>NI</given-names></author> <author><surname>Frolov</surname> <given-names>VM</given-names></author> <author><surname>Tarakanovskaya</surname> <given-names>MG</given-names></author> <author><surname>Batdelger</surname> <given-names>D</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV co-infected</title> <source>TB Immunotherapy</source> in press
<author><surname>Reitman</surname> <given-names>S</given-names></author> <author><surname>Frankel</surname> <given-names>S</given-names></author> <title>A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases</title> <source>Am J Clin Pathol</source> <year>1957</year> <volume>28</volume> <fpage>56</fpage> - <lpage>63</lpage>
<author><surname>Ostrovski&#301</surname>; <given-names>VK</given-names></author> <author><surname>Asanov</surname> <given-names>BM</given-names></author> <author><surname>Iangolenko</surname> <given-names>DV</given-names></author> <title>Some blood indices and the leukocytic index of intoxication in tuberculosis, pneumonias, abscesses, and cancer of the lung</title> <source>Probl Tuberk Bolezn Legk</source> <year>2005</year> <volume>3</volume> <fpage>43</fpage> - <lpage>46</lpage>
<author><surname>Zaitzeva</surname> <given-names>SI</given-names></author> <author><surname>Matveeva</surname> <given-names>SL</given-names></author> <author><surname>Gerasimova</surname> <given-names>TG</given-names></author> <author><surname>Pashkov</surname> <given-names>YN</given-names></author> <author><surname>Butov</surname> <given-names>DA</given-names></author> <author><surname>Pylypchuk</surname> <given-names>VS</given-names></author> <author><surname>Frolov</surname> <given-names>VM</given-names></author> <author><surname>Kutsyna</surname> <given-names>GA</given-names></author> <title>Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator</title> <source>Dzherelo Clin Microbiol Infect</source> <year>2009</year> <volume>15</volume> <fpage>1154</fpage> - <lpage>1162</lpage>
<author><surname>Veenstra</surname> <given-names>H</given-names></author> <author><surname>Baumann</surname> <given-names>R</given-names></author> <author><surname>Carroll</surname> <given-names>NM</given-names></author> <author><surname>Lukey</surname> <given-names>PT</given-names></author> <author><surname>Kidd</surname> <given-names>M</given-names></author> <author><surname>Beyers</surname> <given-names>N</given-names></author> <author><surname>Bolliger</surname> <given-names>CT</given-names></author> <author><surname>van Helden</surname> <given-names>PD</given-names></author> <author><surname>Walzl</surname> <given-names>G</given-names></author> <title>Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders</title> <source>Clin Exp Immunol</source> <year>2006</year> <volume>145</volume> <fpage>252</fpage> - <lpage>260</lpage>
<author><surname>Saukkonen</surname> <given-names>JJ</given-names></author> <author><surname>Cohn</surname> <given-names>DL</given-names></author> <author><surname>Jasmer</surname> <given-names>RM</given-names></author> <author><surname>Schenker</surname> <given-names>S</given-names></author> <author><surname>Jereb</surname> <given-names>JA</given-names></author> <author><surname>Nolan</surname> <given-names>CM</given-names></author> <author><surname>Peloquin</surname> <given-names>CA</given-names></author> <author><surname>Gordin</surname> <given-names>FM</given-names></author> <author><surname>Nunes</surname> <given-names>D</given-names></author> <author><surname>Strader</surname> <given-names>DB</given-names></author> <author><surname>Bernardo</surname> <given-names>J</given-names></author> <author><surname>Venkataramanan</surname> <given-names>R</given-names></author> <author><surname>Sterling</surname> <given-names>TR</given-names></author> <title>ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee An official ATS statement: hepatotoxicity of antituberculosis therapy</title> <source>Am J Respir Crit Care Med</source> <year>2006</year> <volume>174</volume> <fpage>935</fpage> - <lpage>952</lpage>
<author><surname>Vasantha</surname> <given-names>M</given-names></author> <author><surname>Gopi</surname> <given-names>PG</given-names></author> <author><surname>Subramani</surname> <given-names>R</given-names></author> <title>Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS</title>) <source>Indian J Tuberc</source> <year>2009</year> <volume>56</volume> <fpage>5</fpage> - <lpage>9</lpage>
<author><surname>Yew</surname> <given-names>WW</given-names></author> <author><surname>Leung</surname> <given-names>CC</given-names></author> <title>Prognostic significance of early weight gain in underweight patients with tuberculosis</title> <source>Am J Respir Crit Care Med</source> <year>2006</year> <volume>174</volume> <fpage>236</fpage> - <lpage>237</lpage>
<author><surname>Majumdar</surname> <given-names>A</given-names></author> <author><surname>Kamble</surname> <given-names>PD</given-names></author> <author><surname>Harinath</surname> <given-names>BC</given-names></author> <title>Detection of circulating free and immune-complexed antigen in pulmonary tuberculosis using cocktail of antibodies to Mycobacterium tuberculosis excretory secretory antigens by peroxidase enzyme immunoassay</title> <source>Indian J Tuberc</source> <year>2010</year> <volume>57</volume> <fpage>67</fpage> - <lpage>74</lpage>
<author><surname>Vilaplana</surname> <given-names>C</given-names></author> <author><surname>Montan&#233</surname>; <given-names>E</given-names></author> <author><surname>Pinto</surname> <given-names>S</given-names></author> <author><surname>Barriocanal</surname> <given-names>AM</given-names></author> <author><surname>Domenech</surname> <given-names>G</given-names></author> <author><surname>Torres</surname> <given-names>F</given-names></author> <author><surname>Cardona</surname> <given-names>PJ</given-names></author> <author><surname>Costa</surname> <given-names>J</given-names></author> <title>Double-blind, randomized, placebo-controlled Phase I clinical trial of the therapeutical antituberculous vaccine</title> <source>RUTI Vaccine</source> <year>2010</year> <volume>28</volume> <fpage>1106</fpage> - <lpage>1116</lpage>
<author><surname>Stanford</surname> <given-names>J</given-names></author> <author><surname>Stanford</surname> <given-names>C</given-names></author> <author><surname>Grange</surname> <given-names>J</given-names></author> <title>Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis</title> <source>Front Biosci</source> <year>2004</year> <volume>9</volume> <fpage>1701</fpage> - <lpage>1719</lpage>
<author><surname>Zhao</surname> <given-names>G-R</given-names></author> <author><surname>Feng</surname> <given-names>D-H</given-names></author> <title>A systematic review of inactivated Mycobacterium phlei injection for adjunctive treatment of drug resistant pulmonary tuberculosis</title> <source>Pharm J Chin PLA</source> <year>2009</year> <volume>25</volume> <fpage>361</fpage> - <lpage>364</lpage>
<author><surname>Nyasulu</surname> <given-names>PS</given-names></author> <title>Role of adjunctive Mycobacterium w immunotherapy for tuberculosis</title> <source>J Exp Clin Med</source> <year>2010</year> <volume>2</volume> <fpage>123</fpage> - <lpage>129</lpage>
<author><surname>Svistunova</surname> <given-names>AS</given-names></author> <author><surname>Pinegin</surname> <given-names>BV</given-names></author> <author><surname>Selitskaia</surname> <given-names>RP</given-names></author> <author><surname>Arshinova</surname> <given-names>SS</given-names></author> <author><surname>Klimova</surname> <given-names>EG</given-names></author> <author><surname>Andronova</surname> <given-names>TM</given-names></author> <author><surname>Batyrov</surname> <given-names>FA</given-names></author> <author><surname>Simonova</surname> <given-names>AV</given-names></author> <title>The use of immunomodulator likopid in the combined treatment pulmonary tuberculosis</title> <source>Probl Tuberk</source> <year>2002</year> <volume>3</volume> <fpage>21</fpage> - <lpage>25</lpage>
<author><surname>Lei</surname> <given-names>JP</given-names></author> <author><surname>Xiong</surname> <given-names>GL</given-names></author> <author><surname>Hu</surname> <given-names>QF</given-names></author> <author><surname>Li</surname> <given-names>Y</given-names></author> <author><surname>Zong</surname> <given-names>PL</given-names></author> <author><surname>Tu</surname> <given-names>SH</given-names></author> <author><surname>Tu</surname> <given-names>RY</given-names></author> <title>Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis</title> <source>Zhonghua Yu Fang Yi Xue Za Zhi</source> <year>2008</year> <volume>42</volume> <fpage>86</fpage> - <lpage>89</lpage>
<author><surname>Kaufmann</surname> <given-names>SH</given-names></author> <title>Is the development of a new tuberculosis vaccine possible</title>? <source>Nat Med</source> <year>2000</year> <volume>6</volume> <fpage>955</fpage> - <lpage>960</lpage>
<author><surname>Kato</surname> <given-names>S</given-names></author> <author><surname>Tokunaga</surname> <given-names>O</given-names></author> <author><surname>Yoshiyama</surname> <given-names>T</given-names></author> <title>Analysis of Koch"s phenomenon by BCG vaccination with the multi-puncture method in Japan</title> <source>Kekkaku</source> <year>2010</year> <volume>85</volume> <fpage>782</fpage> - <lpage>785</lpage>
<author><surname>Repique</surname> <given-names>CJ</given-names></author> <author><surname>Li</surname> <given-names>A</given-names></author> <author><surname>Collins</surname> <given-names>FM</given-names></author> <author><surname>Morris</surname> <given-names>SL</given-names></author> <title>DNA Immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge</title> <source>Infect Immun</source> <year>2002</year> <volume>70</volume> <fpage>3318</fpage> - <lpage>3323</lpage>
<author><surname>Moreira</surname> <given-names>AL</given-names></author> <author><surname>Tsenova</surname> <given-names>L</given-names></author> <author><surname>Aman</surname> <given-names>MH</given-names></author> <author><surname>Bekker</surname> <given-names>L-G</given-names></author> <author><surname>Freeman</surname> <given-names>S</given-names></author> <author><surname>Mangaliso</surname> <given-names>B</given-names></author> <author><surname>Schr&#246;der</surname> <given-names>U</given-names></author> <author><surname>Jagirdar</surname> <given-names>J</given-names></author> <author><surname>Rom</surname> <given-names>WN</given-names></author> <author><surname>Tovey</surname> <given-names>MG</given-names></author> <author><surname>Freedman</surname> <given-names>VH</given-names></author> <author><surname>Kaplan</surname> <given-names>G</given-names></author> <title>Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice</title> <source>Infect Immun</source> <year>2002</year> <volume>70</volume> <fpage>2100</fpage> - <lpage>2107</lpage>
<author><surname>Basaraba</surname> <given-names>RJ</given-names></author> <author><surname>Izzo</surname> <given-names>AA</given-names></author> <author><surname>Brandt</surname> <given-names>L</given-names></author> <author><surname>Orme</surname> <given-names>IM</given-names></author> <title>Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations</title> <source>Vaccine</source> <year>2006</year> <volume>24</volume> <fpage>280</fpage> - <lpage>286</lpage>
<author><surname>Radaeva</surname> <given-names>TV</given-names></author> <author><surname>Nikonenko</surname> <given-names>BV</given-names></author> <author><surname>Kapina</surname> <given-names>MA</given-names></author> <author><surname>Mishchenko</surname> <given-names>VV</given-names></author> <author><surname>Apt</surname> <given-names>AS</given-names></author> <title>Experimental approaches to designing vaccines against tuberculous infection reactivation</title> <source>Probl Tuberk Bolezn Legk</source> <year>2006</year> <volume>5</volume> <fpage>45</fpage> - <lpage>48</lpage>
<author><surname>Cruz</surname> <given-names>A</given-names></author> <author><surname>Fraga</surname> <given-names>AG</given-names></author> <author><surname>Fountain</surname> <given-names>JJ</given-names></author> <author><surname>Rangel-Moreno</surname> <given-names>J</given-names></author> <author><surname>Torrado</surname> <given-names>E</given-names></author> <author><surname>Saraiva</surname> <given-names>M</given-names></author> <author><surname>Pereira</surname> <given-names>DR</given-names></author> <author><surname>Randall</surname> <given-names>TD</given-names></author> <author><surname>Pedrosa</surname> <given-names>J</given-names></author> <author><surname>Cooper</surname> <given-names>AM</given-names></author> <author><surname>Castro</surname> <given-names>AG</given-names></author> <title>Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis</title> <source>J Exp Med</source> <year>2010</year> <volume>207</volume> <fpage>1609</fpage> - <lpage>1616</lpage>
<author><surname>Derrick</surname> <given-names>SC</given-names></author> <author><surname>Perera</surname> <given-names>LP</given-names></author> <author><surname>Dheenadhayalan</surname> <given-names>V</given-names></author> <author><surname>Yang</surname> <given-names>A</given-names></author> <author><surname>Kolibab</surname> <given-names>K</given-names></author> <author><surname>Morris</surname> <given-names>SL</given-names></author> <title>The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis</title> <source>Vaccine</source> <year>2008</year> <volume>26</volume> <fpage>6092</fpage> - <lpage>6098</lpage>
<author><surname>Roth</surname> <given-names>AE</given-names></author> <author><surname>Benn</surname> <given-names>CS</given-names></author> <author><surname>Ravn</surname> <given-names>H</given-names></author> <author><surname>Rodrigues</surname> <given-names>A</given-names></author> <author><surname>Lisse</surname> <given-names>IM</given-names></author> <author><surname>Yazdanbakhsh</surname> <given-names>M</given-names></author> <author><surname>Whittle</surname> <given-names>H</given-names></author> <author><surname>Aaby</surname> <given-names>P</given-names></author> <title>Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau</title> <source>BMJ</source> <year>2010</year> <volume>340</volume> <fpage>c671</fpage>
<author><surname>Silin</surname> <given-names>DS</given-names></author> <author><surname>Lyubomska</surname> <given-names>OV</given-names></author> <author><surname>Jirathitikal</surname> <given-names>V</given-names></author> <author><surname>Bourinbaiar</surname> <given-names>AS</given-names></author> <title>Oral vaccination: where we are</title>? <source>Expert Opin Drug Deliv</source> <year>2007</year> <volume>4</volume> <fpage>323</fpage> - <lpage>340</lpage>
<author><surname>Zaitzeva</surname> <given-names>SI</given-names></author> <author><surname>Matveeva</surname> <given-names>SL</given-names></author> <author><surname>Gerasimova</surname> <given-names>TG</given-names></author> <author><surname>Pashkov</surname> <given-names>YuN</given-names></author> <author><surname>Butov</surname> <given-names>DA</given-names></author> <author><surname>Pylypchuk</surname> <given-names>VS</given-names></author> <author><surname>Frolov</surname> <given-names>VM</given-names></author> <author><surname>Kutsyna</surname> <given-names>GA</given-names></author> <title>Efficacy and safety of phytoconcentrate Dzherelo (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy</title> <source>Res J Med Sci</source> <year>2009</year> <volume>3</volume> <fpage>36</fpage> - <lpage>41</lpage>
<author><surname>Churchyard</surname> <given-names>GJ</given-names></author> <author><surname>Kaplan</surname> <given-names>G</given-names></author> <author><surname>Fallows</surname> <given-names>D</given-names></author> <author><surname>Wallis</surname> <given-names>RS</given-names></author> <author><surname>Onyebujoh</surname> <given-names>P</given-names></author> <author><surname>Rook</surname> <given-names>GA</given-names></author> <title>Advances in immunotherapy for tuberculosis treatment</title> <source>Clin Chest Med</source> <year>2009</year> <volume>30</volume> <fpage>769</fpage> - <lpage>782</lpage>
<author><surname>Thaiss</surname> <given-names>CA</given-names></author> <author><surname>Kaufmann</surname> <given-names>SH</given-names></author> <title>Toward novel vaccines against tuberculosis: current hopes and obstacles</title> <source>Yale J Biol Med</source> <year>2010</year> <volume>83</volume> <fpage>209</fpage> - <lpage>215</lpage>
<author><surname>Dheda</surname> <given-names>K</given-names></author> <author><surname>Schwander</surname> <given-names>SK</given-names></author> <author><surname>Zhu</surname> <given-names>B</given-names></author> <author><surname>van Zyl-Smit</surname> <given-names>RN</given-names></author> <author><surname>Zhang</surname> <given-names>Y</given-names></author> <title>The immunology of tuberculosis: from bench to bedside</title> <source>Respirology</source> <year>2010</year> <volume>15</volume> <fpage>433</fpage> - <lpage>450</lpage>
Biochemie and Pathobiochemie 7th Springer <other>Berlin, Heidelberg, New York</other> <year>2003</year>
<author><surname>Samuelsson</surname> <given-names>B</given-names></author> <author><surname>Morgenstern</surname> <given-names>R</given-names></author> <author><surname>Jakobsson</surname> <given-names>P. J</given-names></author> <title>Membrane prostaglandin E synthase-1: a novel therapeutic target</title> <source>Pharmacol. Rev</source> <year>2007</year> <volume>59</volume>
<author><surname>Mehrotra</surname> <given-names>S</given-names></author> <author><surname>Morimiya</surname> <given-names>A</given-names></author> <author><surname>Agarwal</surname> <given-names>B</given-names></author> <author><surname>Konger</surname> <given-names>R</given-names></author> <author><surname>Badve</surname> <given-names>S</given-names></author> <title>Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy</title> <source>J. Pathol</source> <year>2006</year> <volume>208</volume>
<author><surname>Friesen</surname> <given-names>R. W</given-names></author> <author><surname>Mancini</surname> <given-names>J. A</given-names></author> <title>Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target</title> <source>J. Med. Chem</source> <year>2008</year> <volume>51</volume>
<author><surname>Thoren</surname> <given-names>S</given-names></author> <author><surname>Jakobsson</surname> <given-names>P. J</given-names></author> <title>Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4</title> <source>Eur. J. Biochem</source> <year>2000</year> <volume>267</volume>
<author><surname>Quraishi</surname> <given-names>O</given-names></author> <author><surname>Mancini</surname> <given-names>J. A</given-names></author> <author><surname>Riendeau</surname> <given-names>D</given-names></author> <title>Inhibition of inducible prostaglandin E (2) synthase by 15-deoxy-delta (12, 14)-prostaglandin J (2) and polyunsaturated fatty acids</title> <source>Biochem. Pharmacol</source> <year>2002</year> <volume>63</volume>
<author><surname>Riendeau</surname> <given-names>D</given-names></author> <author><surname>Aspiotis</surname> <given-names>R</given-names></author> <author><surname>Ethier</surname> <given-names>D</given-names></author> <author><surname>Gareau</surname> <given-names>Y</given-names></author> <author><surname>Grimm</surname> <given-names>E. L</given-names></author> <author><surname>Guay</surname> <given-names>J</given-names></author> <author><surname>Guiral</surname> <given-names>S</given-names></author> <author><surname>Juteau</surname> <given-names>H</given-names></author> <author><surname>Mancini</surname> <given-names>J. A</given-names></author> <author><surname>Methot</surname> <given-names>N</given-names></author> <author><surname>Rubin</surname> <given-names>J</given-names></author> <author><surname>Friesen</surname> <given-names>R. W</given-names></author> <title>Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886</title> <source>Bioorg. Med. Chem. Lett</source> <year>2005</year> <volume>15</volume>
<author><surname>AbdulHameed</surname> <given-names>M. D</given-names></author> <author><surname>Hamza</surname> <given-names>A</given-names></author> <author><surname>Liu</surname> <given-names>J</given-names></author> <author><surname>Huang</surname> <given-names>X</given-names></author> <author><surname>Zhan</surname> <given-names>C. G</given-names></author> <title>Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure&#8211;activity correlation</title> <source>J. Chem. Inf. Model</source> <year>2008</year> <volume>48</volume>
<author><surname>Cote</surname> <given-names>B</given-names></author> <author><surname>Boulet</surname> <given-names>L</given-names></author> <author><surname>Brideau</surname> <given-names>C</given-names></author> <author><surname>Claveau</surname> <given-names>D</given-names></author> <author><surname>Ethier</surname> <given-names>D</given-names></author> <author><surname>Frenette</surname> <given-names>R</given-names></author> <author><surname>Gagnon</surname> <given-names>M</given-names></author> <author><surname>Giroux</surname> <given-names>A</given-names></author> <author><surname>Guay</surname> <given-names>J</given-names></author> <author><surname>Guiral</surname> <given-names>S</given-names></author> <author><surname>Mancini</surname> <given-names>J</given-names></author> <author><surname>Martins</surname> <given-names>E</given-names></author> <author><surname>Masse</surname> <given-names>F</given-names></author> <author><surname>Methot</surname> <given-names>N</given-names></author> <author><surname>Riendeau</surname> <given-names>D</given-names></author> <author><surname>Rubin</surname> <given-names>J</given-names></author> <author><surname>Xu</surname> <given-names>D</given-names></author> <author><surname>Yu</surname> <given-names>H</given-names></author> <author><surname>Ducharme</surname> <given-names>Y</given-names></author> <author><surname>Friesen</surname> <given-names>R. W</given-names></author> <title>Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors</title> <source>Bioorg. Med. Chem. Lett</source> <year>2007</year> <volume>17</volume>
<author><surname>Claveau</surname> <given-names>D</given-names></author> <author><surname>Sirinyan</surname> <given-names>M</given-names></author> <author><surname>Guay</surname> <given-names>J</given-names></author> <author><surname>Gordon</surname> <given-names>R</given-names></author> <author><surname>Chan</surname> <given-names>C. C</given-names></author> <author><surname>Bureau</surname> <given-names>Y</given-names></author> <author><surname>Riendeau</surname> <given-names>D</given-names></author> <author><surname>Mancini</surname> <given-names>J. A</given-names></author> <title>Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model</title> <source>J. Immunol</source> <year>2003</year> <volume>170</volume>
<author><surname>San Juan</surname> <given-names>A. A</given-names></author> <author><surname>Cho</surname> <given-names>S. J</given-names></author> <title>3D-QSAR study of microsomal prostaglandin E2 synthase (mPGES-1) inhibitors</title> <source>J. Mol. Model</source> <year>2007</year> <volume>13</volume>
<author><surname>Jakobsson</surname> <given-names>P. J</given-names></author> <author><surname>Morgenstern</surname> <given-names>R</given-names></author> <author><surname>Mancini</surname> <given-names>J</given-names></author> <author><surname>Ford-Hutchinson</surname> <given-names>A</given-names></author> <author><surname>Persson</surname> <given-names>B</given-names></author> <title>Common structural features of MAPEG&#8212;a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism</title> <source>Protein Sci</source> <year>1999</year> <volume>8</volume>
<author><surname>Jegerschold</surname> <given-names>C</given-names></author> <author><surname>Pawelzik</surname> <given-names>S. C</given-names></author> <author><surname>Purhonen</surname> <given-names>P</given-names></author> <author><surname>Bhakat</surname> <given-names>P</given-names></author> <author><surname>Gheorghe</surname> <given-names>K. R</given-names></author> <author><surname>Gyobu</surname> <given-names>N</given-names></author> <author><surname>Mitsuoka</surname> <given-names>K</given-names></author> <author><surname>Morgenstern</surname> <given-names>R</given-names></author> <author><surname>Jakobsson</surname> <given-names>P. J</given-names></author> <author><surname>Hebert</surname> <given-names>H</given-names></author> <title>Structural basis for induced formation of the inflammatory mediator prostaglandin E2</title> <source>Proc. Natl. Acad. Sci. U.S.A</source> <year>2008</year> <volume>105</volume>
<author><surname>Rorsch</surname> <given-names>F</given-names></author> <author><surname>Wobst</surname> <given-names>I</given-names></author> <author><surname>Zettl</surname> <given-names>H</given-names></author> <author><surname>Schubert-Zsilavecz</surname> <given-names>M</given-names></author> <author><surname>Grosch</surname> <given-names>S</given-names></author> <author><surname>Geisslinger</surname> <given-names>G</given-names></author> <author><surname>Schneider</surname> <given-names>G</given-names></author> <author><surname>Proschak</surname> <given-names>E</given-names></author> <title>Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol</title> <source>J. Med. Chem</source> <year>2010</year> <volume>53</volume>
<author><surname>Koeberle</surname> <given-names>A</given-names></author> <author><surname>Zettl</surname> <given-names>H</given-names></author> <author><surname>Greiner</surname> <given-names>C</given-names></author> <author><surname>Wurglics</surname> <given-names>M</given-names></author> <author><surname>Schubert-Zsilavecz</surname> <given-names>M</given-names></author> <author><surname>Werz</surname> <given-names>O</given-names></author> <title>Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase</title> <source>J. Med. Chem</source> <year>2008</year> <volume>51</volume>
<author><surname>Hessler</surname> <given-names>G</given-names></author> <author><surname>Baringhaus</surname> <given-names>K.-H</given-names></author>. <title>The scaffold hopping potential of pharmacophores</title> <source>Drug Discovery Today: Technol</source> <year>2010</year> <volume>7</volume>
<author><surname>K&#246;berle</surname> <given-names>A</given-names></author> <author><surname>Zettl</surname> <given-names>H</given-names></author> <author><surname>Greiner</surname> <given-names>C</given-names></author> <author><surname>Wurglics</surname> <given-names>M</given-names></author> <author><surname>Schubert-Zsilavecz</surname> <given-names>M</given-names></author> <author><surname>Werz</surname> <given-names>O</given-names></author> <title>Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase</title> <source>J. Med. Chem</source> <year>2008</year> <volume>51</volume>
<source>Int. Pat. Appl. PCT WO</source> <year>2005/123673</year> <volume>A1</volume> <issue>29</issue> <other>Dec</other> <fpage>2005</fpage>
<source>Int. Pat. Appl. PCT WO</source> <year>2005/123675</year> <volume>A1</volume> <issue>29</issue> <other>Dec</other> <fpage>2005</fpage>
<author><surname>Edwards</surname> <given-names>B. S</given-names></author> <author><surname>Bologa</surname> <given-names>C</given-names></author> <author><surname>Young</surname> <given-names>S. M</given-names></author> <author><surname>Balakin</surname> <given-names>K. V</given-names></author> <author><surname>Prossnitz</surname> <given-names>E. R</given-names></author> <author><surname>Savchuck</surname> <given-names>N. P</given-names></author> <author><surname>Sklar</surname> <given-names>L. A</given-names></author> <author><surname>Oprea</surname> <given-names>T. I</given-names></author> <title>Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists</title> <source>Mol. Pharmacol</source> <year>2005</year> <volume>68</volume>
<author><surname>Rohrer</surname> <given-names>S. G</given-names></author> <author><surname>Baumann</surname> <given-names>K</given-names></author> <title>Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data</title> <source>J. Chem. Inf. Model</source> <year>2009</year> <volume>49</volume>
<author><surname>Chen</surname> <given-names>C. Y.-C</given-names></author> <title>Pharmacoinformatics approach for mPGES-1 in anti-inflammation by 3D-QSAR pharmacophore mapping</title> <source>J. Taiwan Inst. Chem. Eng</source> <year>2009</year> <volume>40</volume>
<author><surname>Celotti</surname> <given-names>F</given-names></author> <author><surname>Laufer</surname> <given-names>S</given-names></author> <title>Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept</title> <source>Pharmacol. Res</source> <year>2001</year> <volume>43</volume>
<author><surname>Koeberle</surname> <given-names>A</given-names></author> <author><surname>Siemoneit</surname> <given-names>U</given-names></author> <author><surname>Buhring</surname> <given-names>U</given-names></author> <author><surname>Northoff</surname> <given-names>H</given-names></author> <author><surname>Laufer</surname> <given-names>S</given-names></author> <author><surname>Albrecht</surname> <given-names>W</given-names></author> <author><surname>Werz</surname> <given-names>O</given-names></author> <title>Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1</title> <source>J. Pharmacol. Exp. Ther</source> <year>2008</year> <volume>326</volume>
<author><surname>Peters-Golden</surname> <given-names>M</given-names></author> <author><surname>Henderson</surname> <given-names>W. R</given-names></author> <author><surname>Jr. Leukotrienes</surname> <given-names>N</given-names></author> <source>Engl. J. Med</source> <year>2007</year> <volume>357</volume>
<author><surname>Hopkins</surname> <given-names>A. L</given-names></author> <title>Network pharmacology: the next paradigm in drug discovery</title> <source>Nature Chem. Biol</source> <year>2008</year> <volume>4</volume>
<author><surname>Fischer</surname> <given-names>L</given-names></author> <author><surname>Szellas</surname> <given-names>D</given-names></author> <author><surname>Radmark</surname> <given-names>O</given-names></author> <author><surname>Steinhilber</surname> <given-names>D</given-names></author> <author><surname>Werz</surname> <given-names>O</given-names></author> <title>Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors</title> <source>FASEB J</source> <year>2003</year> <volume>17</volume>
<author><surname>Werz</surname> <given-names>O</given-names></author> <author><surname>Burkert</surname> <given-names>E</given-names></author> <author><surname>Samuelsson</surname> <given-names>B</given-names></author> <author><surname>Radmark</surname> <given-names>O</given-names></author> <author><surname>Steinhilber</surname> <given-names>D</given-names></author> <title>Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes</title> <source>Blood</source> <year>2002</year> <volume>99</volume>
<author><surname>Getz</surname> <given-names>L</given-names></author> <author><surname>Sigurdsson</surname> <given-names>JA</given-names></author> <author><surname>Hetlevik</surname> <given-names>I</given-names></author> <title>Is opportunistic disease prevention in the consultation ethically justifiable</title>? <source>BMJ</source> <year>2003</year> <volume>327</volume> <fpage>498</fpage> - <lpage>500</lpage>
<author><surname>G&#233;rvas</surname> <given-names>J</given-names></author> <author><surname>Heath</surname> <given-names>I</given-names></author> <author><surname>Dur&#225;n</surname> <given-names>A</given-names></author> <title>Clinical prevention: patients" fear and the doctor"s guilt</title> <source>Eur J Gen Pract</source> <year>2009</year> <volume>15</volume> <fpage>122</fpage> - <lpage>4</lpage>
<author><surname>Whitt</surname> <given-names>LA</given-names></author> <title>Value-bifurcation in bioscience: the rhetoric of research justification</title> <source>Perspective on Science</source> <year>1999</year> <volume>7</volume> <fpage>413</fpage> - <lpage>46</lpage>
<author><surname>Pauli</surname> <given-names>HG</given-names></author> <author><surname>White</surname> <given-names>KL</given-names></author> <author><surname>McWhinney</surname> <given-names>IR</given-names></author> <title>Medical education, research, and scientific thinking in the 21st century (part one of three</title>) <source>Educ Health (Abingdon)</source> <year>2000</year> <volume>13</volume> <fpage>15</fpage> - <lpage>25</lpage>
<author><surname>Kuhn</surname> <given-names>TS</given-names></author> <title>The structure of scientific revolutions</title> <issue>2nd edn</issue> <other>Chicago</other> <publisher>University of Chicago Press</publisher> <year>1970</year>
<author><surname>Nowotny</surname> <given-names>H</given-names></author> <author><surname>Scott</surname> <given-names>P</given-names></author> <author><surname>Gibbons</surname> <given-names>M</given-names></author> <title>Rethinking science. Knowledge and the public in an age of uncertainty</title> <other>Oxford</other> <publisher>Blackwell Publishers</publisher> <year>2001</year>
<author><surname>Funtowicz</surname> <given-names>SO</given-names></author> <author><surname>Ravetz</surname> <given-names>JR</given-names></author> <title>Science for the post-normal age</title> <source>Futures</source> <year>1993</year> <volume>25</volume> <fpage>739</fpage> - <lpage>55</lpage>
<author><surname>Haraway</surname> <given-names>D</given-names></author> <title>Situated knowledges: the science question in feminism and the privilege of partial perspective</title> <author><surname>Haraway</surname> <given-names>D</given-names></author> <title>Simians, cyborgs, and women. The reinvention of nature</title> <other>New York</other> <publisher>Routledge</publisher> <year>1991</year> <fpage>182</fpage> - <lpage>201</lpage>
<author><surname>Kenen</surname> <given-names>RH</given-names></author> <title>The at-risk status and technology: a diagnostic invitation and the &#8216;gift&#8217; of knowing</title> <source>Soc Sci Med</source> <year>1996</year> <volume>42</volume> <fpage>145</fpage> - <lpage>53</lpage>
<author><surname>Sibbald</surname> <given-names>B</given-names></author> <author><surname>Bojke</surname> <given-names>C</given-names></author> <author><surname>Gravelle</surname> <given-names>H</given-names></author> <title>National survey of job satisfaction and retirement intentions among general practitioners in England</title> <source>BMJ</source> <year>2003</year> <volume>326</volume> <fpage>22</fpage> - <lpage>4</lpage>
<author><surname>Freeman</surname> <given-names>AC</given-names></author> <author><surname>Sweeny</surname> <given-names>K</given-names></author> <title>Why general practitioners do not implement evidence: a qualitative study</title> <source>BMJ</source> <year>2001</year> <volume>323</volume> <fpage>1100</fpage> - <lpage>2</lpage>
<author><surname>Gubb</surname> <given-names>JD</given-names></author> <title>Commentary: unintended consequences: what of quality outside the QOF</title>? <source>Br J Gen Pract</source> <year>2009</year> <volume>59</volume> <fpage>e173</fpage> - <lpage>4</lpage>
<author><surname>Fisher</surname> <given-names>ES</given-names></author> <author><surname>Welch</surname> <given-names>HG</given-names></author> <title>Avoiding the unintended consequences of growth in medical care: how might more be worse</title>? <source>JAMA</source> <year>1999</year> <volume>281</volume> <fpage>446</fpage> - <lpage>53</lpage>
<author><surname>Reventlow</surname> <given-names>SD</given-names></author> <author><surname>Hvas</surname> <given-names>L</given-names></author> <author><surname>Malterud</surname> <given-names>K</given-names></author> <title>Making the invisible body visible. Bone scans, osteoporosis and women"s bodily experiences</title> <source>Soc Sci Med</source> <year>2006</year> <volume>62</volume> <fpage>2720</fpage> - <lpage>31</lpage>
<author><surname>Hofmann</surname> <given-names>B</given-names></author> <title>On the value-ladenness of technology in medicine</title> <source>Med Health Care Philos</source> <year>2001</year> <volume>4</volume> <fpage>335</fpage> - <lpage>46</lpage>
<author><surname>Hetlevik</surname> <given-names>I</given-names></author> <title>Evidence-based medicine in general practice: a hindrance to optimal medical care</title>? <source>Scand J Prim Health Care</source> <year>2004</year> <volume>22</volume> <fpage>136</fpage> - <lpage>40</lpage>
<author><surname>Kirkengen</surname> <given-names>AL</given-names></author> <author><surname>Ulvestad</surname> <given-names>E</given-names></author> [<title>Heavy burdens and complex disease &#8211; an integrated perspective</title>] <source>Tidsskr Nor Laegeforen</source> <year>2007</year> <volume>127</volume> <fpage>3228</fpage> - <lpage>31</lpage> <url>http://www.tidsskriftet.no/index.php?seks_id_eng=14150&amp;seks_id=1628567</url>
<author><surname>Moynihan</surname> <given-names>R</given-names></author> <author><surname>Smith</surname> <given-names>R</given-names></author> <title>Too much medicine? Almost certainly</title> <source>BMJ</source> <year>2002</year> <volume>324</volume> <fpage>859</fpage> - <lpage>60</lpage>
<author><surname>Gerv&#225;s</surname> <given-names>J</given-names></author> <author><surname>Starfield</surname> <given-names>B</given-names></author> <author><surname>Heath</surname> <given-names>I</given-names></author> <title>Is clinical prevention better than cure</title>? <source>Lancet</source> <year>2008</year> <volume>372</volume> <fpage>1997</fpage> - <lpage>9</lpage>
<author><surname>Malterud</surname> <given-names>K</given-names></author> <title>The legitimacy of clinical knowledge: towards a medical epidemiology embracing the art of medicine</title> <source>Theor Med</source> <year>1995</year> <volume>16</volume> <fpage>183</fpage> - <lpage>98</lpage>
<author><surname>McWhinney</surname> <given-names>IR</given-names></author> <title>Primary care: core values. Core values in a changing world</title> <source>BMJ</source> <year>1998</year> <volume>316</volume> <fpage>1807</fpage> - <lpage>9</lpage>
<author><surname>Patsopoulus</surname> <given-names>NA</given-names></author> <author><surname>Analatos</surname> <given-names>A</given-names></author> <author><surname>Ioannidis</surname> <given-names>JP</given-names></author> <title>Origin and funding of the most frequently cited papers in medicine: database analysis</title> <source>BMJ</source> <year>2006</year> <volume>332</volume> <fpage>1061</fpage> - <lpage>4</lpage>
<author><surname>Agnell</surname> <given-names>M</given-names></author> <title>Industry-sponsored clinical research. a broken system</title> <source>JAMA</source> <year>2008</year> <volume>300</volume> <fpage>1069</fpage> - <lpage>71</lpage>
<author><surname>Patel</surname> <given-names>V</given-names></author> <title>Cultural factors and international epidemiology</title> <source>Br Med Bull</source> <year>2001</year> <volume>57</volume> <fpage>33</fpage> - <lpage>45</lpage>
<author><surname>Foucault</surname> <given-names>M</given-names></author> <author><surname>Gordon</surname> <given-names>C</given-names></author> <title>Power/knowledge: selected interviews and other writings</title> <year>1972&#8211;77</year> <other>Brighton</other> <publisher>Harvester Press</publisher> <year>1980</year>
<author><surname>Dean</surname> <given-names>K</given-names></author> <title>The role of methods in maintaining orthodox beliefs in health research</title> <source>Soc Sci Med</source> <year>2004</year> <volume>58</volume> <fpage>675</fpage> - <lpage>85</lpage>
Royal Society, Royal <source>Academy of Engineering Nanosciences and Nanotechnologies: opportunities and uncertainties</source> <year>2004</year> <url>http://www.nanotec.org.uk/finalReport.htm</url>
<author><surname>Wait</surname> <given-names>J. R</given-names></author> <author><surname>IEEE</surname> <given-names>J</given-names></author> <source>Oceanic Eng</source> <year>1977</year> <volume>2</volume> <fpage>161</fpage> - <lpage>172</lpage>
<author><surname>Brillouin</surname> <given-names>L</given-names></author> <source>Wave Propagation and Group Velocity</source> <year>1960</year> <publisher>Academic Press</publisher> <other>New York</other>
<author><surname>Taylor</surname> <given-names>J. D</given-names></author> <source>Introduction to Ultra-Wideband Radar Systems</source> <year>1994</year> <publisher>CRC Press</publisher> <other>New York</other>
<author><surname>Barrett</surname> <given-names>T. W</given-names></author> <source>Energy Transfer &amp; Propagation and the Dielectrics of Materials: Transient Versus Steady State Effects. Proceedings of the First Los Alamos Symposium</source> <year>1991</year> <publisher>CRC</publisher> <other>New York</other>
<author><surname>Fowler</surname> <given-names>C</given-names></author> <author><surname>Entzminger</surname> <given-names>J</given-names></author> <author><surname>Corum</surname>, <given-names>J</given-names></author> <source>IEEE Aerosp. Electron. Syst. Mag</source> <year>1990</year> <volume>5</volume> <issue>11</issue> <fpage>45</fpage> - <lpage>48</lpage>
<author><surname>Fowler</surname> <given-names>C. A</given-names></author> <source>IEEE Aerosp. Electron. Syst. Mag</source> <year>1992</year> <volume>12</volume> <fpage>3</fpage> - <lpage>5</lpage>
<author><surname>Griffiths</surname> <given-names>H.D</given-names></author>. <author><surname>Baker</surname> <given-names>C.J</given-names></author>. <author><surname>Fernandez</surname> <given-names>A</given-names></author> <author><surname>Davies</surname> <given-names>J.B</given-names></author>. <author><surname>Cullen</surname> <given-names>A.L</given-names></author>. <title>Use and Application of Precursor Waveforms. 1st EMRS</title> <source>DTC Technical Conference, Edinburgh</source> <year>2004</year>
<author><surname>Olson</surname> <given-names>T</given-names></author> <title>Precursor-based HRR for Foliage Penetration: a 10&#8211;15dB</title> Win. AFOSR Electromaghetics Workshop <other>San</other> <publisher>Antonio</publisher>, <other>January</other> <volume>8&#8211;10</volume> <fpage>2004</fpage>
<author><surname>Olson</surname> <given-names>T</given-names></author> <title>Precursor-based HRR for Foliage Penetration; Technical</title> <source>Report</source> <year>2003</year> <publisher>The University of Florida</publisher>
<author><surname>Black</surname> <given-names>D. L</given-names></author> <source>IEEE Aerosp. Electron. Syst. Mag</source> <year>1992</year> <volume>1</volume> <fpage>320</fpage> - <lpage>326</lpage>
<author><surname>Choi</surname> <given-names>S. H</given-names></author> &#<author><surname>214;sterberg</surname> <given-names>U. L</given-names></author> <source>Phys. Rev. Lett</source> <year>2004</year> <volume>92</volume> <fpage>193903</fpage>
<author><surname>Fox</surname> <given-names>A. E</given-names></author> &#<author><surname>214;sterberg</surname> <given-names>U. L</given-names></author> <source>Opt. Express</source> <year>2006</year> <volume>14</volume> <fpage>3689</fpage> - <lpage>3693</lpage>
<author><surname>Lukofsky</surname> <given-names>D</given-names></author> <author><surname>Jeong</surname> <given-names>H</given-names></author> <author><surname>Bessette</surname> <given-names>J</given-names></author> &#<author><surname>214;sterberg</surname> <given-names>U</given-names></author> <source>PIERS Online</source> <year>2008</year> <volume>4</volume> <fpage>854</fpage> - <lpage>858</lpage>
&#<author><surname>214;sterberg</surname> <given-names>U.L</given-names></author>. <author><surname>Andersson</surname> <given-names>D</given-names></author> <author><surname>Lisak</surname> <given-names>M</given-names></author> <source>Opt. Commun</source> <year>2007</year> <volume>277</volume> <fpage>5</fpage> - <lpage>13</lpage>
<author><surname>Li</surname> <given-names>J. C</given-names></author> <author><surname>Alexander</surname> <given-names>D. R</given-names></author> <author><surname>Shang</surname> <given-names>H. F</given-names></author> <author><surname>Parali</surname> <given-names>U</given-names></author> <author><surname>Doerr</surname> <given-names>D. W</given-names></author> <author><surname>Bruce</surname> <given-names>J. C</given-names></author> <author><surname>III Wang</surname> <given-names>H</given-names></author> <source>Opt. Express</source> <year>2007</year> <volume>15</volume> <fpage>1939</fpage> - <lpage>1945</lpage>
<author><surname>Okawachi</surname> <given-names>Y</given-names></author> <author><surname>Slepkov</surname> <given-names>A. D</given-names></author> <author><surname>Agha</surname> <given-names>I. H</given-names></author> <author><surname>Geraghty</surname> <given-names>D. F</given-names></author> <author><surname>Gaeta</surname> <given-names>A. L</given-names></author> <source>J. Opt. Soc. Am. A</source> <year>2007</year> <volume>24</volume> <fpage>3343</fpage> - <lpage>3347</lpage>
<author><surname>Roberts</surname> <given-names>T. M</given-names></author> <source>Phys. Rev. Lett</source> <year>2004</year> <volume>92</volume> <fpage>193903</fpage>
<author><surname>Alfano</surname> <given-names>R. R</given-names></author> <author><surname>Birman</surname> <given-names>J. L</given-names></author> <author><surname>Ni</surname> <given-names>X</given-names></author> <author><surname>Alrubaiee</surname> <given-names>M</given-names></author> <author><surname>Das</surname> <given-names>B. B</given-names></author> <source>Phys. Rev. Lett</source> <year>2005</year> <volume>94</volume> <fpage>239401</fpage> - <fpage>1</fpage> - <lpage>5</lpage>
<author><surname>Ni</surname> <given-names>X</given-names></author> <author><surname>Alfano</surname> <given-names>R. R</given-names></author> <source>Opt. Express</source> <year>2006</year> <volume>94</volume> <fpage>4188</fpage> - <lpage>4194</lpage>
<author><surname>Jeong</surname> <given-names>H</given-names></author> <author><surname>Dawes</surname> <given-names>A. M. C</given-names></author> <author><surname>Gauthier</surname> <given-names>D</given-names></author> <source>J. Phys. Rev. Lett</source> <year>2006</year> <volume>96</volume> <fpage>143901</fpage> - <fpage>1</fpage> - <lpage>4</lpage>
<author><surname>Pleshko</surname> <given-names>P</given-names></author> <author><surname>Palocz</surname> <given-names>I</given-names></author> <source>Phys. Rev. Lett</source> <year>1969</year> <volume>22</volume> <fpage>1201</fpage> - <lpage>1204</lpage>
<author><surname>Klauder</surname> <given-names>J. R</given-names></author> <author><surname>IEE</surname></author> <source>P-Radar Son Nav</source> <year>2005</year> <volume>152</volume> <fpage>23</fpage> - <lpage>28</lpage>
<author><surname>Gibson</surname> <given-names>U. J</given-names></author> &#<author><surname>214;sterberg</surname> <given-names>U.L</given-names></author>. <source>Opt. Express</source> <year>2005</year> <volume>13</volume> <fpage>2105</fpage> - <lpage>2110</lpage>
<author><surname>Jackson</surname> <given-names>J. D</given-names></author> <source>Classical Electrodynamics</source> <year>1975</year> <other>Wiley New York</other>
<author><surname>Oughstun</surname> <given-names>K. E</given-names></author> <author><surname>Balictsis</surname> <given-names>C. M</given-names></author> <source>Phys. Rev. Lett</source> <year>1996</year> <volume>77</volume> <fpage>2210</fpage> - <lpage>2213</lpage>
<author><surname>Schulz-Dubois</surname> <given-names>E. O</given-names></author> <source>IEEE Trans. Microwave Theory Tech</source> <year>1970</year> <volume>18</volume> <fpage>455</fpage> - <lpage>460</lpage>
<author><surname>Stenius</surname> <given-names>P</given-names></author> <author><surname>York</surname> <given-names>B</given-names></author> <source>IEEE Antennas Propag. Mag</source> <year>1995</year> <volume>37</volume> <fpage>39</fpage> - <lpage>44</lpage>
<author><surname>Allen</surname> <given-names>L</given-names></author> <author><surname>Eberly</surname> <given-names>J. H</given-names></author> <source>Optical Resonance and Two-Level Atoms</source> <year>1987</year> <publisher>Dover Publications</publisher> <other>New York</other>
<author><surname>Oughstun</surname> <given-names>K. E</given-names></author> <author><surname>Sherman</surname> <given-names>G. E</given-names></author> <title>Electromagnetic Pulse Propagation in Causal</title> <source>Dielectrics</source> <year>1994</year> <other>Springer-Verlag Berlin</other>
<author><surname>Roberts</surname> <given-names>T. M</given-names></author> <source>Electron. Lett</source> <year>2002</year> <volume>38</volume> <fpage>679</fpage> - <lpage>680</lpage>
<author><surname>Fraser-Smith</surname> <given-names>A. C</given-names></author> <author><surname>Bubenik</surname> <given-names>D. M</given-names></author> <author><surname>Villard</surname> <given-names>O. G</given-names></author> <author><surname>Jr</surname></author> <title>Air/undersea Communication at Ultra-low-frequencies Using Airborne Loop Antennas; Technical</title> <source>Report 4207-6</source> <year>1977</year> <other>Stanford, CA</other> <publisher>Stanford University Electronics Laboratory</publisher>
<author><surname>Ziolkowski</surname> <given-names>R. W</given-names></author> <author><surname>Arnold</surname> <given-names>J. M</given-names></author> <author><surname>Gogny</surname> <given-names>D. M</given-names></author> <source>Phys. Rev. A</source> <year>1995</year> <volume>52</volume> <fpage>3082</fpage> - <lpage>3092</lpage>
<author><surname>Stenger</surname> <given-names>J</given-names></author> <author><surname>Madsen</surname> <given-names>D</given-names></author> <author><surname>Hamm</surname> <given-names>P</given-names></author> <author><surname>Nibbering</surname> <given-names>E</given-names></author> <author><surname>Elsaesser</surname> <given-names>T</given-names></author> <source>Phys. Rev. Lett</source> <year>2001</year> <volume>87</volume> <fpage>27401</fpage>
<author><surname>Gale</surname> <given-names>G</given-names></author> <author><surname>Gallot</surname> <given-names>G</given-names></author> <author><surname>Hache</surname> <given-names>F</given-names></author> <author><surname>Lascoux</surname> <given-names>N</given-names></author> <source>Phys. Rev. Lett</source> <year>1999</year> <volume>82</volume> <fpage>1068</fpage> - <lpage>1071</lpage>
<author><surname>Callegari</surname> <given-names>A</given-names></author> <author><surname>Theule</surname> <given-names>P</given-names></author> <author><surname>Muenter</surname> <given-names>J</given-names></author> <author><surname>Tolchenov</surname> <given-names>R</given-names></author> <author><surname>Zobov</surname> <given-names>N</given-names></author> <author><surname>Polyansky</surname> <given-names>O</given-names></author> <author><surname>Tennyson</surname> <given-names>J</given-names></author> <author><surname>Rizzo</surname> <given-names>T</given-names></author> <source>Science</source> <year>2002</year> <volume>297</volume> <fpage>993</fpage> - <lpage>995</lpage>
<author><surname>Segelstein</surname> <given-names>D.J</given-names></author>. <source>The Complex Refractive Index of Water. Master"s Thesis, University of Missouri</source> <other>Kansas City, MO, USA</other> <year>1981</year>
<author><surname>Crisp</surname> <given-names>M. D</given-names></author> <source>Phys. Rev. A</source> <year>1969</year> <volume>1</volume> <fpage>1605</fpage> - <lpage>1611</lpage>
<author><surname>Vogel</surname> <given-names>A</given-names></author> <author><surname>Noack</surname> <given-names>J</given-names></author> <author><surname>Nahen</surname> <given-names>K</given-names></author> <author><surname>Theisen</surname> <given-names>D</given-names></author> <author><surname>Busch</surname> <given-names>S</given-names></author> <author><surname>Parlitz</surname> <given-names>U</given-names></author> <author><surname>Hammer</surname> <given-names>D</given-names></author> <author><surname>Noojin</surname> <given-names>G</given-names></author> <author><surname>Rockwell</surname> <given-names>B</given-names></author> <author><surname>Birngruber</surname> <given-names>R</given-names></author> <source>Phys. Rev. B</source> <year>1999</year> <volume>68</volume> <fpage>271</fpage> - <lpage>280</lpage>
<author><surname>McCall</surname> <given-names>S. L</given-names></author> <author><surname>Hahn</surname> <given-names>E. L</given-names></author> <source>Phys. Rev</source> <year>1969</year> <volume>183</volume> <fpage>452</fpage> - <lpage>457</lpage>
<author><surname>Aalbers</surname> <given-names>MB</given-names></author> <title>What types of neighbourhoods are redlined</title>? <source>Journal of Housing and the Built Environment</source> <year>2007</year> <volume>22</volume> <fpage>177</fpage> - <lpage>198</lpage>
<author><surname>Aassve</surname> <given-names>A</given-names></author> <author><surname>Billari</surname> <given-names>FC</given-names></author> <author><surname>Mazzuco</surname> <given-names>S</given-names></author> <author><surname>Ongaro</surname> <given-names>F</given-names></author> <title>Leaving home: A comparative analysis of ECHP data</title> <source>Journal of European Social Policy</source> <year>2002</year> <volume>12</volume> <fpage>259</fpage> - <lpage>275</lpage>
<author><surname>Allison</surname> <given-names>PD</given-names></author> <title>Discrete-time methods for the analysis of event histories</title> <source>Sociological Methodology</source> <year>1982</year> <volume>13</volume> <fpage>61</fpage> - <lpage>98</lpage>
<author><surname>Aquilino</surname> <given-names>WS</given-names></author> <title>Family structure and home-leaving: A further specification of the relationship</title> <source>Journal of Marriage and the Family</source> <year>1991</year> <volume>53</volume> <fpage>999</fpage> - <lpage>1010</lpage>
<author><surname>Avery</surname> <given-names>R</given-names></author> <author><surname>Goldscheider</surname> <given-names>F</given-names></author> <author><surname>Speare</surname> <given-names>A</given-names></author> <title>Jr Feathered nest/gilded cage: Parental income and leaving home in the transition to adulthood</title> <source>Demography</source> <year>1992</year> <volume>29</volume> <fpage>375</fpage> - <lpage>388</lpage>
<author><surname>Bernhardt</surname> <given-names>E</given-names></author> <author><surname>Gahler</surname> <given-names>M</given-names></author> <author><surname>Goldscheider</surname> <given-names>F</given-names></author> <title>Childhood family structure and routes out of the parental home in Sweden</title> <source>Acta Sociologica</source> <year>2005</year> <volume>48</volume> <fpage>99</fpage> - <lpage>115</lpage>
<author><surname>Bernhardt</surname> <given-names>E</given-names></author> <author><surname>Goldscheider</surname> <given-names>G</given-names></author> <author><surname>Goldscheider</surname> <given-names>F</given-names></author> <author><surname>Bjeren</surname> <given-names>G</given-names></author> <title>Immigration, gender and family transitions to adulthood</title> <source>in Sweden</source> <year>2007</year> <publisher>Lanham University Press of America</publisher>
<author><surname>Billari</surname> <given-names>FC</given-names></author> <author><surname>Liefbroer</surname> <given-names>AC</given-names></author> <author><surname>Should</surname> <given-names>I</given-names></author> <title>stay or should I go? The impact of age norms on leaving home</title> <source>Demography</source> <year>2007</year> <volume>44</volume> <fpage>181</fpage> - <lpage>198</lpage>
<author><surname>Blossfeld</surname> <given-names>H-P</given-names></author> <author><surname>Huinink</surname> <given-names>J</given-names></author> <title>Human capital investments or norms of role transition? How women&#8217;s schooling and career affect the process of family formation</title> <source>American Journal of Sociology</source> <year>1991</year> <volume>97</volume> <fpage>143</fpage> - <lpage>168</lpage>
<author><surname>Bolt</surname> <given-names>G</given-names></author> <title>Turkish and Moroccan couples and their first steps on the Dutch housing market: Co-residence or independence</title>? <source>Journal of Housing and the Built Environment</source> <year>2002</year> <volume>17</volume> <fpage>269</fpage> - <lpage>292</lpage>
<author><surname>Buck</surname> <given-names>N</given-names></author> <author><surname>Scott</surname> <given-names>J</given-names></author> <title>She&#8217;s leaving home: But why? An analysis of young people leaving the parental home</title> <source>Journal of Marriage and the Family</source> <year>1993</year> <volume>55</volume> <fpage>863</fpage> - <lpage>874</lpage>
<author><surname>Dalla Zuanna</surname> <given-names>G</given-names></author> <title>The banquet of aeolus: A familistic interpretation of Italy&#8217;s lowest low fertility</title> <source>Demographic Research</source> <year>2001</year> <volume>4</volume> <issue>article 5</issue> <fpage>133</fpage> - <lpage>162</lpage>
<author><surname>Jong Gierveld</surname> <given-names>J</given-names></author> <author><surname>Liefbroer</surname> <given-names>AC</given-names></author> <author><surname>Beekink</surname> <given-names>E</given-names></author> <title>The effect of parental resources on patterns of leaving home among young adults in the Netherlands</title> <source>European Sociological Review</source> <year>1991</year> <volume>7</volume> <fpage>55</fpage> - <lpage>71</lpage>
<author><surname>Valk</surname> <given-names>HAG</given-names></author> <author><surname>Crul</surname> <given-names>M</given-names></author> <author><surname>Heering</surname> <given-names>L</given-names></author> <title>Union and family formation The position of the Turkish and Moroccan second generation in Amsterdam and</title> <source>Rotterdam</source> <year>2008</year> <other>Amsterdam</other> <publisher>Amsterdam University Press</publisher> <fpage>143</fpage> - <lpage>159</lpage>
<author><surname>Valk</surname> <given-names>HAG</given-names></author> <author><surname>Billari</surname> <given-names>FC</given-names></author> <title>Living arrangements of migrant and Dutch young adults: The family influence disentangled</title> <source>Population Studies</source> <year>2007</year> <volume>61</volume> <fpage>201</fpage> - <lpage>217</lpage>
<author><surname>Valk</surname> <given-names>HAG</given-names></author> <author><surname>Liefbroer</surname> <given-names>AC</given-names></author> <title>Parental influence on union formation preferences among Turkish, Moroccan, and Dutch adolescents in the Netherlands</title> <source>Journal of Cross-Cultural Psychology</source> <year>2007</year> <volume>38</volume> <fpage>487</fpage> - <lpage>505</lpage>
<author><surname>Valk</surname> <given-names>HAG</given-names></author> <author><surname>Liefbroer</surname> <given-names>AC</given-names></author> <title>Timing preferences for women&#8217;s family-life transitions: Intergenerational transmission among migrants and Dutch</title> <source>Journal of Marriage and Family</source> <year>2007</year> <volume>69</volume> <fpage>190</fpage> - <lpage>206</lpage>
<author><surname>Ermisch</surname> <given-names>J</given-names></author> <title>Prices, parents and young people&#8217;s household formation</title> <source>Journal of Urban Economics</source> <year>1999</year> <volume>45</volume> <fpage>47</fpage> - <lpage>71</lpage>
<author><surname>Giuliano</surname> <given-names>P</given-names></author> <title>Living arrangements in Western Europe: Does cultural origin matter</title>? <source>Journal of the European Economic Association</source> <year>2007</year> <volume>5</volume> <fpage>927</fpage> - <lpage>952</lpage>
<author><surname>Glick</surname> <given-names>JE</given-names></author> <author><surname>Hook</surname> <given-names>J</given-names></author> <title>Parents&#8217; coresidence with adult children: Can immigration explain racial and ethnic variation</title>? <source>Journal of Marriage and Family</source> <year>2002</year> <volume>64</volume> <fpage>240</fpage> - <lpage>253</lpage>
<author><surname>Goldscheider</surname> <given-names>FK</given-names></author> <author><surname>Goldscheider</surname> <given-names>C</given-names></author> <title>The historical trajectory of the black family: Ethnic differences in leaving home over the twentieth century</title> <source>The History of the Family</source> <year>1997</year> <volume>2</volume> <fpage>295</fpage> - <lpage>307</lpage>
<author><surname>Goldscheider</surname> <given-names>F</given-names></author> <author><surname>Goldscheider</surname> <given-names>C</given-names></author> <title>The changing transition to adulthood</title>. <source>Leaving and returning home</source> <year>1999</year> <other>Thousand Oaks</other> <publisher>Sage</publisher>
<author><surname>Goldscheider</surname> <given-names>F</given-names></author> <author><surname>Thornton</surname> <given-names>A</given-names></author> <author><surname>Young-DeMarco</surname> <given-names>L</given-names></author> <title>A portrait of the nest leaving process in early adulthood</title> <source>Demography</source> <year>1993</year> <volume>30</volume> <fpage>683</fpage> - <lpage>699</lpage>
<author><surname>Haurin</surname> <given-names>RJ</given-names></author> <author><surname>Haurin</surname> <given-names>DR</given-names></author> <author><surname>Hendershott</surname> <given-names>PH</given-names></author> <author><surname>Bourassa</surname> <given-names>SC</given-names></author> <title>Home or alone: The costs of independent living for youth</title> <source>Social Science Research</source> <year>1997</year> <volume>26</volume> <fpage>135</fpage> - <lpage>152</lpage>
<author><surname>Koc</surname> <given-names>I</given-names></author> <title>The timing of leaving parental home and its linkages to other life course events in Turkey</title> <source>Marriage &amp; Family Review</source> <year>2007</year> <volume>42</volume> <fpage>29</fpage> - <lpage>47</lpage>
<author><surname>Lancaster</surname> <given-names>T</given-names></author> <title>The econometric analysis of transition</title> <source>data</source> <year>1990</year> <other>Cambridge</other> <publisher>Cambridge University Press</publisher>
<author><surname>Lesthaeghe</surname> <given-names>R</given-names></author> <author><surname>Surkyn</surname> <given-names>J</given-names></author> <title>Cultural dynamics and economic theories of fertility change</title> <source>Population and Development Review</source> <year>1988</year> <volume>14</volume> <fpage>1</fpage> - <lpage>45</lpage>
<author><surname>McLanahan</surname> <given-names>S</given-names></author> <title>Diverging destinies: How children are faring under the second demographic transition</title> <source>Demography</source> <year>2004</year> <volume>41</volume> <fpage>607</fpage> - <lpage>627</lpage>
<author><surname>Merz</surname> <given-names>EM</given-names></author> <author><surname>Ozeke-Kocabas</surname> <given-names>E</given-names></author> <author><surname>Oort</surname> <given-names>FJ</given-names></author> <author><surname>Schuengel</surname> <given-names>C</given-names></author> <title>Intergenerational family solidarity: Value differences between immigrant groups and generations</title> <source>Journal of Family Psychology</source> <year>2009</year> <volume>23</volume> <fpage>291</fpage> - <lpage>300</lpage>
<author><surname>Mitchell</surname> <given-names>BA</given-names></author> <author><surname>Wister</surname> <given-names>AV</given-names></author> <author><surname>Gee</surname> <given-names>EM</given-names></author> <title>The ethnic and family nexus of homeleaving and returning among Canadian young adults</title> <source>Canadian Journal of Sociology</source> <year>2004</year> <volume>29</volume> <fpage>543</fpage> - <lpage>576</lpage>
<author><surname>Mulder</surname> <given-names>CH</given-names></author> <author><surname>Clark</surname> <given-names>WAV</given-names></author> <title>Leaving home and leaving the state: Evidence from the United States</title> <source>International Journal of Population Geography</source> <year>2000</year> <volume>6</volume> <fpage>423</fpage> - <lpage>437</lpage>
<author><surname>Mulder</surname> <given-names>CH</given-names></author> <author><surname>Hooimeijer</surname> <given-names>P</given-names></author> <title>Leaving home in the Netherlands: Timing and first housing</title> <source>Journal of Housing and the Built Environment</source> <year>2002</year> <volume>17</volume> <fpage>237</fpage> - <lpage>268</lpage>
<author><surname>Murphy</surname> <given-names>M</given-names></author> <author><surname>Wang</surname> <given-names>D</given-names></author> <title>Family and sociodemographic influences on patterns of leaving home in postwar</title> <source>Britain Demography</source> <year>1998</year> <volume>35</volume> <fpage>293</fpage> - <lpage>305</lpage>
<author><surname>Nilsson</surname> <given-names>K</given-names></author> <author><surname>Strandh</surname> <given-names>M</given-names></author> <title>Nest leaving in Sweden: The importance of early educational and labor market careers</title> <source>Journal of Marriage and the Family</source> <year>1999</year> <volume>61</volume> <fpage>1068</fpage> - <lpage>1079</lpage>
<author><surname>Raley</surname> <given-names>RK</given-names></author> <title>Increasing fertility in cohabiting unions: Evidence for the second demographic transition in the United</title> <source>States? Demography</source> <year>2001</year> <volume>38</volume> <fpage>59</fpage> - <lpage>66</lpage>
<author><surname>Beek</surname> <given-names>KWH</given-names></author> <author><surname>Koopmans</surname> <given-names>CC</given-names></author> <author><surname>Praag</surname> <given-names>BMS</given-names></author> <title>Shopping at the labour market: A real tale of fiction</title> <source>European Economic Review</source> <year>1997</year> <volume>4</volume> <fpage>295</fpage> - <lpage>31</lpage>
<author><surname>Kaa</surname> <given-names>DJ</given-names></author> <title>Europe&#8217;s second demographic transition</title> <source>Population Bulletin</source> <year>1987</year> <volume>42</volume> <fpage>1</fpage> - <lpage>57</lpage>
<author><surname>Whittington</surname> <given-names>LA</given-names></author> <author><surname>Peters</surname> <given-names>HE</given-names></author> <title>Economic incentives for financial and residential independence</title> <source>Demography</source> <year>1996</year> <volume>33</volume> <fpage>82</fpage> - <lpage>97</lpage>
<author><surname>Morton</surname> <given-names>DL</given-names></author> <author><surname>Wen</surname> <given-names>DR</given-names></author> <author><surname>Wong</surname> <given-names>JH</given-names></author> <title>Technical details of intraoperative lymphatic mapping for early stage melanoma</title> <source>Archives of Surgery</source> <year>1992</year> <volume>127</volume> <issue>4</issue> <fpage>392</fpage> - <lpage>399</lpage>
<author><surname>McMasters</surname> <given-names>KM</given-names></author> <author><surname>Dirk Noyes</surname> <given-names>R</given-names></author> <author><surname>Reintgen</surname> <given-names>DS</given-names></author> <title>Lessons learned from the sunbelt melanoma trial</title> <source>Journal of Surgical Oncology</source> <year>2004</year> <volume>86</volume> <issue>4</issue> <fpage>212</fpage> - <lpage>223</lpage>
<author><surname>Bagaria</surname> <given-names>SP</given-names></author> <author><surname>Faries</surname> <given-names>MB</given-names></author> <author><surname>Morton</surname> <given-names>DL</given-names></author> <title>Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute</title> <source>Journal of Surgical Oncology</source> <year>2010</year> <volume>101</volume> <issue>8</issue> <fpage>669</fpage> - <lpage>676</lpage>
<author><surname>Uhara</surname> <given-names>H</given-names></author> <author><surname>Takata</surname> <given-names>M</given-names></author> <author><surname>Saida</surname> <given-names>T</given-names></author> <title>Sentinel lymph node biopsy in Japan</title> <source>International Journal of Clinical Oncology</source> <year>2009</year> <volume>14</volume> <issue>6</issue> <fpage>490</fpage> - <lpage>496</lpage>
<author><surname>McMasters</surname> <given-names>KM</given-names></author> <author><surname>Chao</surname> <given-names>C</given-names></author> <author><surname>Wong</surname> <given-names>S</given-names></author> <title>Interval sentinel lymph nodes in melanoma</title> <source>Archives of Surgery</source> <year>2002</year> <volume>137</volume> <issue>5</issue> <fpage>543</fpage> - <lpage>549</lpage>
<author><surname>Silverio</surname> <given-names>A</given-names></author> <author><surname>McRae</surname> <given-names>M</given-names></author> <author><surname>Ariyan</surname> <given-names>S</given-names></author> <author><surname>Narayan</surname> <given-names>D</given-names></author> <title>Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma</title> <source>Annals of Plastic Surgery</source> <year>2010</year> <volume>65</volume> <issue>4</issue> <fpage>418</fpage> - <lpage>424</lpage>
<author><surname>Morton</surname> <given-names>DL</given-names></author> <author><surname>Thompson</surname> <given-names>JF</given-names></author> <author><surname>Alistair</surname> <given-names>MD</given-names></author> <title>Sentinel-node biopsy or nodal observation in melanoma</title> <source>New England Journal of Medicine</source> <year>2006</year> <volume>355</volume> <issue>13</issue> <fpage>1307</fpage> - <lpage>1317</lpage>
<author><surname>Xing</surname> <given-names>Y</given-names></author> <author><surname>Badgwell</surname> <given-names>BD</given-names></author> <author><surname>Ross</surname> <given-names>MI</given-names></author> <title>Lymph node ratio predicts disease-specific survival in melanoma patients</title> <source>Cancer</source> <year>2009</year> <volume>115</volume> <issue>11</issue> <fpage>2505</fpage> - <lpage>2513</lpage>
<author><surname>Uren</surname> <given-names>RF</given-names></author> <author><surname>Howman-Giles</surname> <given-names>R</given-names></author> <author><surname>Thompson</surname> <given-names>JF</given-names></author> <title>Interval nodes: the forgotten sentinel nodes in patients with melanoma</title> <source>Archives of Surgery</source> <year>2000</year> <volume>135</volume> <issue>10</issue> <fpage>1168</fpage> - <lpage>1172</lpage>
<author><surname>Thompson</surname> <given-names>JF</given-names></author> <author><surname>Uren</surname> <given-names>RF</given-names></author> <author><surname>Shaw</surname> <given-names>HM</given-names></author> <title>Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy</title> <source>Journal of the American College of Surgeons</source> <year>1999</year> <volume>189</volume> <issue>2</issue> <fpage>195</fpage> - <lpage>204</lpage>
<author><surname>Vidal-Sicart</surname> <given-names>S</given-names></author> <author><surname>Pons</surname> <given-names>F</given-names></author> <author><surname>Fuertes</surname> <given-names>S</given-names></author> <title>Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary</title>? <source>European Journal of Nuclear Medicine and Molecular Imaging</source> <year>2004</year> <volume>31</volume> <issue>7</issue> <fpage>945</fpage> - <lpage>949</lpage>
<author><surname>Lens</surname> <given-names>M</given-names></author> <title>Sentinel lymph node biopsy in melanoma patients</title> <source>JEADV</source> <year>2010</year> <volume>24</volume> <issue>9</issue> <fpage>1005</fpage> - <lpage>1012</lpage>
<author><surname>Manganoni</surname> <given-names>AM</given-names></author> <author><surname>Farisoglio</surname> <given-names>C</given-names></author> <author><surname>Facchetti</surname> <given-names>F</given-names></author> <author><surname>Simoncini</surname> <given-names>E</given-names></author> <author><surname>Calzavara Pinton</surname> <given-names>PG</given-names></author> <title>Sentinel lymph node biopsy in melanoma: assessment of risk</title> <source>Annals of Surgical Oncology</source> <year>2008</year> <volume>15</volume> <issue>9 p</issue> <fpage>2626</fpage>
<author><surname>Balch</surname> <given-names>CM</given-names></author> <author><surname>Gershenwald</surname> <given-names>JE</given-names></author> <author><surname>Soong</surname> <given-names>SJ</given-names></author> <source>Final version of</source> <year>2009</year> <title>AJCC melanoma staging and classification</title> <source>Journal of Clinical Oncology</source> <year>2009</year> <volume>27</volume> <issue>36</issue> <fpage>6199</fpage> - <lpage>6206</lpage>
<author><surname>Gershenwald</surname> <given-names>JE</given-names></author> <author><surname>Soong</surname> <given-names>SJ</given-names></author> <author><surname>Balch</surname> <given-names>CM</given-names></author> <year>2010</year> <title>TNM staging system for cutaneous melanoma...and beyond</title> <source>Annals of Surgical Oncology</source> <year>2010</year> <volume>17</volume> <fpage>1475</fpage> - <lpage>1477</lpage>
<author><surname>Vu&#269;eti&#263</surname>; <given-names>B</given-names></author> <author><surname>Rogan</surname> <given-names>SA</given-names></author> <author><surname>Balenovi&#263</surname>; <given-names>A</given-names></author> <title>The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma</title> <source>Wiener Klinische Wochenschrift</source> <year>2006</year> <volume>118</volume> <issue>9-10</issue> <fpage>286</fpage> - <lpage>293</lpage>
<author><surname>Vidal-Sicart</surname> <given-names>S</given-names></author> <author><surname>Pons</surname> <given-names>F</given-names></author> <author><surname>Piulachs</surname> <given-names>J</given-names></author> <author><surname>Castel</surname> <given-names>T</given-names></author> <author><surname>Palou</surname> <given-names>J</given-names></author> <author><surname>Herranz</surname> <given-names>R</given-names></author> <title>Mid-arm sentinel lymph nodes showing surprising drainage from a malignant melanoma in the forearm</title> <source>Clinical Nuclear Medicine</source> <year>1998</year> <volume>23</volume> <issue>5</issue> <fpage>273</fpage> - <lpage>274</lpage>
<author><surname>Norman</surname> <given-names>J</given-names></author> <author><surname>Cruse</surname> <given-names>CW</given-names></author> <author><surname>Espinosa</surname> <given-names>C</given-names></author> <title>Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma</title> <source>American Journal of Surgery</source> <year>1991</year> <volume>162</volume> <issue>5</issue> <fpage>432</fpage> - <lpage>437</lpage>
<author><surname>Uren</surname> <given-names>RF</given-names></author> <author><surname>Howman-Giles</surname> <given-names>RB</given-names></author> <author><surname>Thompson</surname> <given-names>JF</given-names></author> <author><surname>Shaw</surname> <given-names>HM</given-names></author> <author><surname>McCarthy</surname> <given-names>WH</given-names></author> <title>Lymphatic drainage from periumbilical skin to internal mammary nodes</title> <source>Clinical Nuclear Medicine</source> <year>1995</year> <volume>20</volume> <issue>3</issue> <fpage>254</fpage> - <lpage>255</lpage>
<author><surname>Roozendaal</surname> <given-names>GK</given-names></author> <author><surname>De Vries</surname> <given-names>JDH</given-names></author> <author><surname>Van Poll</surname> <given-names>D</given-names></author> <title>Sentinel nodes outside lymph node basins in patients with melanoma</title> <source>British Journal of Surgery</source> <year>2001</year> <volume>88</volume> <issue>2</issue> <fpage>305</fpage> - <lpage>308</lpage>
<author><surname>Matsumoto</surname> <given-names>T</given-names></author> <author><surname>Shibata</surname> <given-names>S</given-names></author> <author><surname>Yasue</surname> <given-names>S</given-names></author> <title>Interval sentinel lymph nodes in patients with cutaneous melanoma: a single-institution study in Japan</title> <source>Journal of Dermatology</source> <year>2010</year> <volume>37</volume> <issue>7</issue> <fpage>629</fpage> - <lpage>634</lpage>
<author><surname>Banai</surname> <given-names>K</given-names></author> <author><surname>Ahissar</surname> <given-names>M</given-names></author> <title>Auditory processing deficits in dyslexia: task or stimulus related</title>? <source>Cerebral Cortex</source> <year>2006</year> <volume>16</volume> <fpage>1718</fpage> - <lpage>1728</lpage>
<author><surname>Ba&#351;ar</surname> <given-names>E</given-names></author> <author><surname>Ba&#351;ar-Eroglu</surname> <given-names>C</given-names></author> <author><surname>Karakas</surname> <given-names>S</given-names></author> <author><surname>Sch&#252;rmann</surname> <given-names>M</given-names></author> <title>Oscillatory brain theory: a new trend in neuroscience</title> <source>IEEE Engineering in Medicine and Biology</source> <year>1999</year> <volume>18</volume> <fpage>56</fpage> - <lpage>66</lpage>
<author><surname>Ba&#351;ar</surname> <given-names>E</given-names></author> <author><surname>Ba&#351;ar-Eroglu</surname> <given-names>C</given-names></author> <author><surname>Parnefjord</surname> <given-names>R</given-names></author> <author><surname>Rahn</surname> <given-names>E</given-names></author> <author><surname>Sch&#252;rmann</surname> <given-names>M</given-names></author> <author><surname>Ba&#351;ar</surname> <given-names>E</given-names></author> <author><surname>Bullock</surname> <given-names>TH</given-names></author> <title>Evoked potentials: ensembles of brain induced rhythmicities in the alpha, theta and gamma ranges Induced rhythms in the brain</title> <year>1992</year> <other>Boston, MA</other> <publisher>Birkhauser</publisher> <fpage>155</fpage> - <lpage>181</lpage>
<author><surname>Bishop</surname> <given-names>DVM</given-names></author> <source>The Test for Reception of Grammar, version 2</source> (<other>TROG-2</other>) <year>2003</year> <other>London</other> <publisher>Pearson</publisher>
<author><surname>Bishop</surname> <given-names>DVM</given-names></author> <author><surname>Hardiman</surname> <given-names>MJ</given-names></author> <title>Measurement of mismatch negativity in individuals: a study using single-trial analysis</title> <source>Psychophysiology</source> <year>2010</year> <volume>47</volume> <fpage>697</fpage> - <lpage>705</lpage>
<author><surname>Bishop</surname> <given-names>DVM</given-names></author> <author><surname>Hardiman</surname> <given-names>M</given-names></author> <author><surname>Uwer</surname> <given-names>R</given-names></author> <author><surname>von Suchodoletz</surname> <given-names>W</given-names></author> <title>Maturation of the long-latency auditory ERP: step function changes at start and end of adolescence</title> <source>Developmental Science</source> <year>2007</year> <volume>10</volume> <fpage>576</fpage> - <lpage>587</lpage>
<author><surname>Boersma</surname> <given-names>P</given-names></author> <author><surname>Weenink</surname> <given-names>D</given-names></author> <title>Praat: a system for doing phonetics by computer</title> <source>Glot International</source> <year>2005</year> <volume>5</volume> <issue>9/10</issue> <fpage>341</fpage> - <lpage>345</lpage>
<author><surname>Buss</surname> <given-names>E</given-names></author> <author><surname>Hall</surname> <given-names>JW</given-names></author> <author><surname>Grose</surname> <given-names>JH</given-names></author> <title>Psychometric functions for pure tone intensity discrimination: slope differences in school-aged children and adults</title> <source>Journal of the Acoustical Society of America</source> <year>2009</year> <volume>125</volume> <fpage>1050</fpage> - <lpage>1058</lpage>
&#<author><surname>268;eponien&#233</surname>; <given-names>R</given-names></author> <author><surname>Lepist&#246</surname>; <given-names>T</given-names></author> <author><surname>Soininen</surname> <given-names>M</given-names></author> <author><surname>Aronen</surname> <given-names>E</given-names></author> <author><surname>Alku</surname> <given-names>P</given-names></author> <author><surname>N&#228;&#228;t&#228;nen</surname> <given-names>R</given-names></author> <title>Event-related potentials associated with sound discrimination versus novelty detection in children</title> <source>Psychophysiology</source> <year>2004</year> <volume>41</volume> <fpage>130</fpage> - <lpage>141</lpage>
<author><surname>Cheour</surname> <given-names>M</given-names></author> <author><surname>Korpilahti</surname> <given-names>P</given-names></author> <author><surname>Martynova</surname> <given-names>O</given-names></author> <author><surname>Lang</surname> <given-names>AH</given-names></author> <title>Mismatch negativity and late discriminative negativity in investigating speech perception and learning in children and infants</title> <source>Audiology and Neuro-Otology</source> <year>2001</year> <volume>6</volume> <fpage>2</fpage> - <lpage>11</lpage>
<author><surname>Cheour</surname> <given-names>M</given-names></author> <author><surname>Lepp&#228;nen</surname> <given-names>PH</given-names></author> <author><surname>Kraus</surname> <given-names>N</given-names></author> <title>Mismatch negativity (MMN) as a tool for investigating auditory discrimination and sensory memory in infants and children</title> <source>Clinical Neurophysiology</source> <year>2000</year> <volume>111</volume> <fpage>4</fpage> - <lpage>16</lpage>
<author><surname>Craig</surname> <given-names>C</given-names></author> <source>GoldWave (Version 5.23)</source> <year>2008</year> <other>St Johns, Newfoundland</other> <publisher>GoldWave Inc</publisher> [Sound Editing Program]
<author><surname>Delorme</surname> <given-names>A</given-names></author> <author><surname>Makeig</surname> <given-names>S</given-names></author> <title>EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis (sccn.ucsd.edu/eeglab</title>/) <source>Journal of Neuroscience Methods</source> <year>2004</year> <volume>134</volume> <fpage>9</fpage> - <lpage>21</lpage>
<author><surname>Eggermont</surname> <given-names>JJ</given-names></author> <author><surname>Ponton</surname> <given-names>CW</given-names></author> <title>Auditory-evoked potential studies of cortical maturation in normal hearing and implanted children: correlations with changes in structure and speech perception</title> <source>Acta Otolaryngologica</source> <year>2003</year> <volume>123</volume> <fpage>249</fpage> - <lpage>252</lpage>
<author><surname>Field</surname> <given-names>A</given-names></author> <title>Discovering statistics using</title> <source>SPSS</source> <year>2005</year> <issue>2nd edn</issue> <other>London</other> <publisher>Sage Publications</publisher>
<author><surname>Findlay</surname> <given-names>JM</given-names></author> <title>Estimates on probability functions: a more virulent</title> <source>PEST Perception and Psychophysics</source> <year>1978</year> <volume>23</volume> <fpage>181</fpage> - <lpage>185</lpage>
<author><surname>Fuentemilla</surname> <given-names>L</given-names></author> <author><surname>Marco-Pallar&#233;s</surname> <given-names>J</given-names></author> <author><surname>Grau</surname> <given-names>C</given-names></author> <title>Modulation of spectral power and phase resetting of EEG contributes differentially to the generation of auditory event-related potentials</title> <source>NeuroImage</source> <year>2006</year> <volume>30</volume> <fpage>909</fpage> - <lpage>916</lpage>
<author><surname>Fuentemilla</surname> <given-names>L</given-names></author> <author><surname>Marco-Pallar&#233;s</surname> <given-names>J</given-names></author> <author><surname>M&#252;nte</surname> <given-names>TF</given-names></author> <author><surname>Grau</surname> <given-names>C</given-names></author> <title>Theta EEG oscillatory activity and auditory change detection</title> <source>Brain Research</source> <year>2008</year> <volume>1220</volume> <fpage>93</fpage> - <lpage>101</lpage>
<author><surname>Gomot</surname> <given-names>M</given-names></author> <author><surname>Giard</surname> <given-names>MH</given-names></author> <author><surname>Roux</surname> <given-names>S</given-names></author> <author><surname>Barthelemy</surname> <given-names>C</given-names></author> <author><surname>Bruneau</surname> <given-names>N</given-names></author> <title>Maturation of frontal and temporal components of mismatch negativity (MMN) in children</title> <source>NeuroReport</source> <year>2000</year> <volume>11</volume> <fpage>3109</fpage> - <lpage>3112</lpage>
<author><surname>Guthrie</surname> <given-names>D</given-names></author> <author><surname>Buchwald</surname> <given-names>J</given-names></author> <title>Significance testing of difference potentials</title> <source>Psychophysiology</source> <year>1991</year> <volume>28</volume> <fpage>240</fpage> - <lpage>244</lpage>
<author><surname>Halliday</surname> <given-names>L</given-names></author> <author><surname>Bishop</surname> <given-names>DVM</given-names></author> <title>Frequency discrimination and literacy skills in children with mild to moderate sensorineural hearing loss</title> <source>Journal of Speech, Language and Hearing Research</source> <year>2005</year> <volume>48</volume> <fpage>1187</fpage> - <lpage>1203</lpage>
<author><surname>Heath</surname> <given-names>SM</given-names></author> <author><surname>Bishop</surname> <given-names>DVM</given-names></author> <author><surname>Hogben</surname> <given-names>JH</given-names></author> <author><surname>Roach</surname> <given-names>NW</given-names></author> <title>Psychophysical indices of perceptual functioning in dyslexia: a psychometric analysis</title> <source>Cognitive Neuropsychology</source> <year>2006</year> <volume>23</volume> <fpage>905</fpage> - <lpage>929</lpage>
<author><surname>Hsiao</surname> <given-names>FJ</given-names></author> <author><surname>Wu</surname> <given-names>ZA</given-names></author> <author><surname>Ho</surname> <given-names>LT</given-names></author> <author><surname>Lin</surname> <given-names>YY</given-names></author> <title>Theta oscillation during auditory change detection: an MEG study</title> <source>Biological Psychology</source> <year>2009</year> <volume>81</volume> <issue>1</issue> <fpage>58</fpage> - <lpage>66</lpage>
<author><surname>Illing</surname> <given-names>R</given-names></author> <title>Maturation and plasticity of the central auditory system</title> <source>Acta Otolaryngol Suppl</source> <year>2004</year> <volume>552</volume> <fpage>6</fpage> - <lpage>10</lpage>
<author><surname>Kolev</surname> <given-names>V</given-names></author> <author><surname>Rosso</surname> <given-names>OA</given-names></author> <author><surname>Yordanova</surname> <given-names>J</given-names></author> <title>A transient dominance of theta ERP component characterizes passive auditory processing: evidence from a developmental study</title> <source>NeuroReport</source> <year>2001</year> <volume>12</volume> <fpage>2791</fpage> - <lpage>2796</lpage>
<author><surname>Korpilahti</surname> <given-names>P</given-names></author> <author><surname>Krause</surname> <given-names>CM</given-names></author> <author><surname>Holopainen</surname> <given-names>IE</given-names></author> <author><surname>Lang</surname> <given-names>AH</given-names></author> <title>Early and late mismatch negativity elicited by words and speech-like stimuli in children</title> <source>Brain and Language</source> <year>2001</year> <volume>76</volume> <fpage>332</fpage> - <lpage>339</lpage>
<author><surname>Kraus</surname> <given-names>N</given-names></author> <author><surname>Koch</surname> <given-names>DB</given-names></author> <author><surname>McGee</surname> <given-names>TJ</given-names></author> <author><surname>Nicol</surname> <given-names>TG</given-names></author> <author><surname>Cunningham</surname> <given-names>J</given-names></author> <title>Speech&#8211;sound discrimination in school-age children: psychophysical and neurophysiological measures</title> <source>Journal of Speech, Language, and Hearing Research</source> <year>1999</year> <volume>42</volume> <fpage>1042</fpage> - <lpage>1060</lpage>
<author><surname>Kraus</surname> <given-names>N</given-names></author> <author><surname>McGee</surname> <given-names>T</given-names></author> <author><surname>Carrell</surname> <given-names>T</given-names></author> <author><surname>Sharma</surname> <given-names>A</given-names></author> <author><surname>Micco</surname> <given-names>A</given-names></author> <author><surname>Nicol</surname> <given-names>T</given-names></author> <title>Speech-evoked cortical potentials in children</title> <source>Journal of the American Academy of Audiology</source> <year>1993</year> <volume>4</volume> <fpage>238</fpage> - <lpage>248</lpage>
<author><surname>Lenroot</surname> <given-names>RK</given-names></author> <author><surname>Schmitt</surname> <given-names>JE</given-names></author> <author><surname>Ordaz</surname> <given-names>SJ</given-names></author> <author><surname>Wallace</surname> <given-names>GL</given-names></author> <author><surname>Neale</surname> <given-names>MC</given-names></author> <author><surname>Lerch</surname> <given-names>JP</given-names></author> <author><surname>Kendler</surname> <given-names>KS</given-names></author> <author><surname>Evans</surname> <given-names>AC</given-names></author> <author><surname>Giedd</surname> <given-names>JN</given-names></author> <title>Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence</title> <source>Human Brain Mapping</source> <year>2009</year> <volume>30</volume> <fpage>163</fpage> - <lpage>174</lpage>
<author><surname>McGee</surname> <given-names>T</given-names></author> <author><surname>Kraus</surname> <given-names>N</given-names></author> <author><surname>Nicol</surname> <given-names>T</given-names></author> <title>Is it really a mismatch negativity? An assessment of methods for determining response validity in individual subjects</title> <source>Electroencephalography and Clinical Neurophysiology</source> <year>1997</year> <volume>104</volume> <fpage>359</fpage> - <lpage>368</lpage>
<author><surname>Makeig</surname> <given-names>S</given-names></author> <title>Auditory event-related dynamics of the EEG spectrum and effects of exposure to tones</title> <source>Electroencephalography and Clinical Neurophysiology</source> <year>1993</year> <volume>86</volume> <fpage>283</fpage> - <lpage>293</lpage>
<author><surname>Makeig</surname> <given-names>S</given-names></author> <author><surname>Debener</surname> <given-names>S</given-names></author> <author><surname>Onton</surname> <given-names>J</given-names></author> <author><surname>Delorme</surname> <given-names>A</given-names></author> <title>Mining event-related brain dynamics</title> <source>Trends in Cognitive Sciences</source> <year>2004</year> <volume>8</volume> <fpage>204</fpage> - <lpage>210</lpage>
<author><surname>Moore</surname> <given-names>DR</given-names></author> <title>Auditory development and the role of experience</title> <source>British Medical Bulletin</source> <year>2002</year> <volume>63</volume> <fpage>171</fpage> - <lpage>181</lpage>
<author><surname>Moore</surname> <given-names>JK</given-names></author> <author><surname>Guan</surname> <given-names>Y</given-names></author> <title>Cytoarchitectural and axonal maturation in human auditory cortex</title> <source>Journal of the Association for Research in Otolaryngology</source> <year>2001</year> <volume>2</volume> <fpage>297</fpage> - <lpage>311</lpage>
<author><surname>Moore</surname> <given-names>JK</given-names></author> <author><surname>Linthicum</surname> <given-names>FH</given-names></author> <title>The human auditory system: a timeline of development</title> <source>International Journal of Audiology</source> <year>2007</year> <volume>46</volume> <fpage>460</fpage> - <lpage>478</lpage>
<author><surname>M&#252;lller</surname> <given-names>V</given-names></author> <author><surname>Gruber</surname> <given-names>W</given-names></author> <author><surname>Klimesch</surname> <given-names>W</given-names></author> <author><surname>Lindenberger</surname> <given-names>U</given-names></author> <title>Lifespan differences in cortical dynamics of auditory perception</title> <source>Developmental Science</source> <year>2009</year> <volume>12</volume> <fpage>839</fpage> - <lpage>853</lpage>
<author><surname>N&#228;&#228;t&#228;nen</surname> <given-names>R</given-names></author> <author><surname>Lehtokoski</surname> <given-names>A</given-names></author> <author><surname>Lennes</surname> <given-names>M</given-names></author> <author><surname>Cheour</surname> <given-names>M</given-names></author> <author><surname>Huotilainen</surname> <given-names>M</given-names></author> <author><surname>Ilvonen</surname> <given-names>A</given-names></author> <author><surname>Vainio</surname> <given-names>M</given-names></author> <author><surname>Alku</surname> <given-names>P</given-names></author> <author><surname>Ilmoniemi</surname> <given-names>RJ</given-names></author> <author><surname>Luuk</surname> <given-names>A</given-names></author> <author><surname>Allik</surname> <given-names>J</given-names></author> <author><surname>Sinkkonen</surname> <given-names>J</given-names></author> <author><surname>Alho</surname> <given-names>K</given-names></author> <title>Language-specific phoneme representations revealed by electric and magnetic brain responses</title> <source>Nature</source> <year>1997</year> <volume>385</volume> <fpage>432</fpage> - <lpage>434</lpage>
<author><surname>N&#228;&#228;t&#228;nen</surname> <given-names>R</given-names></author> <author><surname>Paavilainen</surname> <given-names>P</given-names></author> <author><surname>Rinne</surname> <given-names>T</given-names></author> <author><surname>Alho</surname> <given-names>K</given-names></author> <title>The mismatch negativity (MMN) in basic research of central auditory processing: a review</title> <source>Clinical Neurophysiology</source> <year>2007</year> <volume>118</volume> <fpage>2544</fpage> - <lpage>2590</lpage>
<author><surname>N&#228;&#228;t&#228;nen</surname> <given-names>R</given-names></author> <author><surname>Pakarinen</surname> <given-names>S</given-names></author> <author><surname>Rinne</surname> <given-names>T</given-names></author> <author><surname>Takegata</surname> <given-names>R</given-names></author> <title>The mismatch negativity (MMN): towards the optimal paradigm</title> <source>Clinical Neurophysiology</source> <year>2004</year> <volume>115</volume> <fpage>140</fpage> - <lpage>144</lpage>
<author><surname>Oades</surname> <given-names>RD</given-names></author> <author><surname>Dittmann-Balcar</surname> <given-names>A</given-names></author> <author><surname>Zerbin</surname> <given-names>D</given-names></author> <title>Development and topography of auditory event-related potentials (ERPs): mismatch and processing negativity in individuals 8&#8211;22 years of age</title> <source>Psychophysiology</source> <year>1997</year> <volume>34</volume> <fpage>677</fpage> - <lpage>693</lpage>
<author><surname>Picton</surname> <given-names>TW</given-names></author> <author><surname>Taylor</surname> <given-names>MJ</given-names></author> <title>Electrophysiological evaluation of human brain development</title> <source>Developmental Neuropsychology</source> <year>2007</year> <volume>31</volume> <fpage>249</fpage> - <lpage>278</lpage>
<author><surname>Sauseng</surname> <given-names>P</given-names></author> <author><surname>Klimesch</surname> <given-names>W</given-names></author> <title>What does phase information of oscillatory brain activity tell us about cognitive processes</title>? <source>Neuroscience and Biobehavioral Reviews</source> <year>2008</year> <volume>32</volume> <fpage>1001</fpage> - <lpage>1013</lpage>
<author><surname>Sayers</surname> <given-names>BM</given-names></author> <author><surname>Beagley</surname> <given-names>HA</given-names></author> <author><surname>Henshall</surname> <given-names>WR</given-names></author> <title>The mechanism of auditory evoked EEG responses</title> <source>Nature</source> <year>1974</year> <volume>247</volume> <fpage>481</fpage> - <lpage>483</lpage>
<author><surname>Sch&#252;rmann</surname> <given-names>M</given-names></author> <author><surname>Ba&#351;ar</surname> <given-names>E</given-names></author> <title>Topography of alpha and theta oscillations upon auditory and visual stimuli in humans</title> <source>Biological Cybernetics</source> <year>1994</year> <volume>72</volume> <fpage>161</fpage> - <lpage>174</lpage>
<author><surname>Shafer</surname> <given-names>VL</given-names></author> <author><surname>Morr</surname> <given-names>ML</given-names></author> <author><surname>Kreuzer</surname> <given-names>JA</given-names></author> <author><surname>Kurtzberg</surname> <given-names>D</given-names></author> <title>Maturation of mismatch negativity in school-aged children</title> <source>Ear and Hearing</source> <year>2000</year> <volume>21</volume> <fpage>242</fpage> - <lpage>251</lpage>
<author><surname>Shahin</surname> <given-names>AJ</given-names></author> <author><surname>Roberts</surname> <given-names>LE</given-names></author> <author><surname>Chau</surname> <given-names>W</given-names></author> <author><surname>Trainor</surname> <given-names>LJ</given-names></author> <author><surname>Miller</surname> <given-names>LM</given-names></author> <title>Music training leads to the development of timbre-specific gamma band activity</title> <source>NeuroImage</source> <year>2008</year> <volume>41</volume> <fpage>113</fpage> - <lpage>122</lpage>
<author><surname>Shahin</surname> <given-names>AJ</given-names></author> <author><surname>Trainor</surname> <given-names>LJ</given-names></author> <author><surname>Roberts</surname> <given-names>LE</given-names></author> <author><surname>Backer</surname> <given-names>KC</given-names></author> <author><surname>Miller</surname> <given-names>LM</given-names></author> <title>Development of auditory phase-locked activity for music sounds</title> <source>Journal of Neurophysiology</source> <year>2010</year> <volume>103</volume> <fpage>218</fpage> - <lpage>229</lpage>
<author><surname>Sutcliffe</surname> <given-names>P</given-names></author> <author><surname>Bishop</surname> <given-names>DVM</given-names></author> <title>Psychophysical design influences frequency discrimination performance in young children</title> <source>Journal of Experimental Child Psychology</source> <year>2005</year> <volume>91</volume> <fpage>249</fpage> - <lpage>270</lpage>
<author><surname>Sutcliffe</surname> <given-names>P</given-names></author> <author><surname>Bishop</surname> <given-names>D</given-names></author> <author><surname>Houghton</surname> <given-names>S</given-names></author> <author><surname>Taylor</surname> <given-names>M</given-names></author> <title>Effect of attentional state on frequency discrimination: a comparison of children with ADHD on and off medication</title> <source>Journal of Speech, Language and Hearing Research</source> <year>2006</year> <volume>49</volume> <fpage>1072</fpage> - <lpage>1084</lpage>
<author><surname>Tang</surname> <given-names>AC</given-names></author> <author><surname>Sutherland</surname> <given-names>MT</given-names></author> <author><surname>McKinney</surname> <given-names>CJ</given-names></author> <title>Validation of SOBI components from high-density</title> <source>EEG NeuroImage</source> <year>2005</year> <volume>25</volume> <issue>2</issue> <fpage>539</fpage> - <lpage>553</lpage>
<author><surname>Torgesen</surname> <given-names>JK</given-names></author> <author><surname>Wagner</surname> <given-names>R</given-names></author> <author><surname>Rashotte</surname> <given-names>C</given-names></author> <source>Test of Word Reading Efficiency (TOWRE)</source> <year>1999</year> <other>New York</other> <publisher>Psychological Corporation</publisher>
<author><surname>Uwer</surname> <given-names>R</given-names></author> <author><surname>Albrecht</surname> <given-names>R</given-names></author> <author><surname>von Suchodoletz</surname> <given-names>W</given-names></author> <title>Automatic processing of tones and speech stimuli in children with specific language impairment</title> <source>Developmental Medicine and Child Neurology</source> <year>2002</year> <volume>44</volume> <fpage>527</fpage> - <lpage>532</lpage>
<author><surname>Wechsler</surname> <given-names>D</given-names></author> <author><surname>Wechsler</surname> <given-names>Abbreviated</given-names></author> <source>Scale of Intelligence</source> <year>1999</year> <other>San Antonio, TX</other> <publisher>Psychological Corporation</publisher>
<author><surname>Werner</surname> <given-names>LA</given-names></author> <author><surname>Marean</surname> <given-names>GC</given-names></author> <title>Human auditory development</title> <year>1996</year> <other>Boulder, CO</other> <publisher>Westview Press</publisher>
<author><surname>Whitford</surname> <given-names>TJ</given-names></author> <author><surname>Rennie</surname> <given-names>CJ</given-names></author> <author><surname>Grieve</surname> <given-names>SM</given-names></author> <author><surname>Clark</surname> <given-names>CR</given-names></author> <author><surname>Gordon</surname> <given-names>E</given-names></author> <author><surname>Williams</surname> <given-names>LM</given-names></author> <title>Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology</title> <source>Human Brain Mapping</source> <year>2007</year> <volume>28</volume> <issue>3</issue> <fpage>228</fpage> - <lpage>237</lpage>
<author><surname>Yordanova</surname> <given-names>J</given-names></author> <author><surname>Kolev</surname> <given-names>V</given-names></author> <author><surname>Schmidt</surname> <given-names>LA</given-names></author>, <author><surname>Segalowitz</surname> <given-names>SJ</given-names></author> <title>Event-related brain oscillations in normal development</title> <source>Developmental psychophysiology: Theory, systems and methods</source> <year>2008</year> <other>New York</other> <publisher>Cambridge University Press</publisher> <fpage>15</fpage> - <lpage>68</lpage>
<author><surname>Bruno</surname> <given-names>JJ</given-names></author> <author><surname>Ellis</surname> <given-names>JJ</given-names></author> <title>Herbal use among US elderly: 2002 National Health Interview Survey</title> <source>Ann Pharmacother</source> <year>2005</year> <volume>39</volume> <fpage>643</fpage> - <lpage>648</lpage>
Slone Epidemiology Center <title>Patterns of Medication Use in the United States 2006. A Report from the</title> <source>Slone Survey</source> <year>2006</year> <other>Boston, Mass</other> <publisher>Slone Epidemiology Center at Boston University</publisher>
CDC <title>Incidence of Diagnosed Diabetes Per 1000 Population Aged 18&#8211;79 Years, by Sex and Age, United States, 1997&#8211;2005</title> <year>2007</year> <other>Atlanta, Georgia</other> <publisher>Centers for Disease Control</publisher> and Prevention (CDC) Available at
<author><surname>Marshall</surname> <given-names>S</given-names></author> <author><surname>Bacote</surname> <given-names>V</given-names></author> <author><surname>Traxinger</surname> <given-names>R</given-names></author> <title>Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance</title> <source>J Biol Chem</source> <year>1991</year> <volume>266</volume> <fpage>4706</fpage> - <lpage>4712</lpage>
<author><surname>Copeland</surname> <given-names>RJ</given-names></author> <author><surname>Bullen</surname> <given-names>JW</given-names></author> <author><surname>Hart</surname> <given-names>GW</given-names></author> <title>Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity</title> <source>Am J Physiol Endocrinol Metab</source> <year>2008</year> <volume>295</volume> <fpage>E17</fpage> - <lpage>28</lpage>
<author><surname>Pham</surname> <given-names>T</given-names></author> <author><surname>Cornea</surname> <given-names>A</given-names></author> <author><surname>Blick</surname> <given-names>KE</given-names></author> <author><surname>Jenkins</surname> <given-names>A</given-names></author> <author><surname>Scofield</surname> <given-names>RH</given-names></author> <title>Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance</title> <source>Am J Med Sci</source> <year>2007</year> <volume>333</volume> <fpage>333</fpage> - <lpage>339</lpage>
<author><surname>Biggee</surname> <given-names>BA</given-names></author> <author><surname>Blinn</surname> <given-names>CM</given-names></author> <author><surname>Nuite</surname> <given-names>M</given-names></author> <author><surname>Silbert</surname> <given-names>JE</given-names></author> <author><surname>McAlindon</surname> <given-names>TE</given-names></author> <title>Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis</title> <source>Ann Rheum Dis</source> <year>2007</year> <volume>66</volume> <fpage>260</fpage> - <lpage>262</lpage>
<author><surname>Dahmer</surname> <given-names>S</given-names></author> <author><surname>Schiller</surname> <given-names>RM</given-names></author> <title>Glucosamine</title> <source>Am Fam Physician</source> <year>2008</year> <volume>78</volume> <fpage>471</fpage> - <lpage>476</lpage>
<author><surname>Shankar</surname> <given-names>RR</given-names></author> <author><surname>Zhu</surname> <given-names>J-S</given-names></author> <author><surname>Baron</surname> <given-names>AD</given-names></author> <title>Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus</title> <source>Metabolism</source> <year>1998</year> <volume>47</volume> <fpage>573</fpage> - <lpage>577</lpage>
<author><surname>Muniyappa</surname> <given-names>R</given-names></author> <author><surname>Karne</surname> <given-names>RJ</given-names></author> <author><surname>Hall</surname> <given-names>G</given-names></author> <title>Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects</title> <source>Diabetes</source> <year>2006</year> <volume>55</volume> <fpage>3142</fpage> - <lpage>3150</lpage>
<author><surname>Quastel</surname> <given-names>JH</given-names></author> <title>Intestinal absorption of sugars and amino acids</title> <source>Am J Clin Nutr</source> <year>1960</year> <volume>8</volume> <fpage>137</fpage> - <lpage>146</lpage>
<author><surname>Hastings</surname> <given-names>TH</given-names></author> <author><surname>Landau</surname> <given-names>BR</given-names></author> <title>Specificity of sugar transport by the intestine of the hamster</title> <source>Am J Physiol</source> <year>1960</year> <volume>198</volume> <fpage>99</fpage> - <lpage>102</lpage>
<author><surname>Neale</surname> <given-names>RJ</given-names></author> <author><surname>Wiseman</surname> <given-names>G</given-names></author> <title>The use of dietary-restricted rat intestine for active transport studies</title> <source>J Physiol</source> <year>1969</year> <volume>205</volume> <fpage>159</fpage> - <lpage>178</lpage>
<author><surname>Faust</surname> <given-names>RG</given-names></author> <author><surname>Leadbetter</surname> <given-names>MG</given-names></author> <author><surname>Plenge</surname> <given-names>RK</given-names></author> <author><surname>McCaslin</surname> <given-names>AJ</given-names></author> <title>Active sugar transport by the small intestine. The effects of sugars, amino acids, hexosamines, sulfhydryl-reacting compounds, and cations on the preferential binding of D-glucose to tris-disrupted brush borders</title> <source>J Gen Physiol</source> <year>1968</year> <volume>52</volume> <fpage>482</fpage> - <lpage>494</lpage>
<author><surname>Hirayama</surname> <given-names>BA</given-names></author> <author><surname>Loo</surname> <given-names>DD</given-names></author> <author><surname>D&#237;ez-Sampedro</surname> <given-names>A</given-names></author> <title>Sodium-dependent reorganization of the sugar-binding site of SGLT1</title> <source>Biochemistry</source> <year>2007</year> <volume>46</volume> <fpage>13391</fpage> - <lpage>1406</lpage>
<author><surname>Roda</surname> <given-names>A</given-names></author> <author><surname>Sabatini</surname> <given-names>L</given-names></author> <author><surname>Barbieri</surname> <given-names>A</given-names></author> <title>Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma</title> <source>J Chromatogr B</source> <year>2006</year> <volume>844</volume> <fpage>119</fpage> - <lpage>126</lpage>
<author><surname>Biggee</surname> <given-names>BA</given-names></author> <author><surname>Blinn</surname> <given-names>CM</given-names></author> <author><surname>McAlindon</surname> <given-names>TE</given-names></author> <author><surname>Nuite</surname> <given-names>M</given-names></author> <author><surname>Silbert</surname> <given-names>JE</given-names></author> <title>Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness</title> <source>Ann Rheum Dis</source> <year>2006</year> <volume>65</volume> <fpage>222</fpage> - <lpage>226</lpage>
<author><surname>Persiani</surname> <given-names>S</given-names></author> <author><surname>Rotini</surname> <given-names>R</given-names></author> <author><surname>Trisolino</surname> <given-names>G</given-names></author> <title>Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose</title> <source>Osteoarthritis Cartilage</source> <year>2007</year> <volume>15</volume> <fpage>764</fpage> - <lpage>772</lpage>
<author><surname>Persiani</surname> <given-names>S</given-names></author> <author><surname>Roda</surname> <given-names>E</given-names></author> <author><surname>Rovati</surname> <given-names>LC</given-names></author> <author><surname>Locatelli</surname> <given-names>M</given-names></author> <author><surname>Giacovelli</surname> <given-names>G</given-names></author> <author><surname>Roda</surname> <given-names>A</given-names></author> <title>Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man</title> <source>Osteoarthritis Cartilage</source> <year>2005</year> <volume>13</volume> <fpage>1041</fpage> - <lpage>1049</lpage>
<author><surname>Setnikar</surname> <given-names>I</given-names></author> <author><surname>Rovati</surname> <given-names>LC</given-names></author> <title>Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review</title> <source>Arzneimittelforschung</source> <year>2001</year> <volume>51</volume> <fpage>699</fpage> - <lpage>725</lpage>
<author><surname>Adebowale</surname> <given-names>A</given-names></author> <author><surname>Du</surname> <given-names>J</given-names></author> <author><surname>Liang</surname> <given-names>Z</given-names></author> <author><surname>Leslie</surname> <given-names>JL</given-names></author> <author><surname>Eddington</surname> <given-names>ND</given-names></author> <title>The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs</title> <source>Biopharm Drug Dispos</source> <year>2002</year> <volume>23</volume> <fpage>217</fpage> - <lpage>225</lpage>
<author><surname>Du</surname> <given-names>J</given-names></author> <author><surname>White</surname> <given-names>N</given-names></author> <author><surname>Eddington</surname> <given-names>ND</given-names></author> <title>The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse</title> <source>Biopharm Drug Dispos</source> <year>2004</year> <volume>25</volume> <fpage>109</fpage> - <lpage>116</lpage>
<author><surname>Laverty</surname> <given-names>S</given-names></author> <author><surname>Sandy</surname> <given-names>JD</given-names></author> <author><surname>Celeste</surname> <given-names>C</given-names></author> <author><surname>Vachon</surname> <given-names>P</given-names></author> <author><surname>Marier</surname> <given-names>J-F</given-names></author> <author><surname>Plaas</surname> <given-names>AH</given-names></author> <title>Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses</title> <source>Arthritis Rheum</source> <year>2005</year> <volume>52</volume> <fpage>181</fpage> - <lpage>191</lpage>
<author><surname>Aghazadeh-Habashi</surname> <given-names>A</given-names></author> <author><surname>Sattari</surname> <given-names>S</given-names></author> <author><surname>Pasutto</surname> <given-names>F</given-names></author> <author><surname>Jamali</surname> <given-names>F</given-names></author> <title>Single dose pharmacokinetics and bioavailability of glucosamine in the rat</title> <source>J Pharm Pharm Sci</source> <year>2002</year> <volume>5</volume> <fpage>181</fpage> - <lpage>184</lpage>
<author><surname>Setnikar</surname> <given-names>I</given-names></author> <author><surname>Palumbo</surname> <given-names>R</given-names></author> <author><surname>Canali</surname> <given-names>S</given-names></author> <author><surname>Zanolo</surname> <given-names>G</given-names></author> <title>Pharmacokinetics of glucosamine in man</title> <source>Arzneimittelforschung</source> <year>1993</year> <volume>43</volume> <fpage>1109</fpage> - <lpage>1113</lpage>
<author><surname>Aghazadeh-Habashi</surname> <given-names>A</given-names></author> <author><surname>Ibrahim</surname> <given-names>A</given-names></author> <author><surname>Carran</surname> <given-names>J</given-names></author> <author><surname>Anastassiades</surname> <given-names>T</given-names></author> <author><surname>Jamali</surname> <given-names>F</given-names></author> <title>Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat</title> <source>J Pharm Pharm Sci</source> <year>2006</year> <volume>9</volume> <fpage>359</fpage> - <lpage>364</lpage>
<author><surname>Crociani</surname> <given-names>F</given-names></author> <author><surname>Alessandrini</surname> <given-names>A</given-names></author> <author><surname>Mucci</surname> <given-names>MM</given-names></author> <author><surname>Biavati</surname> <given-names>B</given-names></author> <title>Degradation of complex carbohydrates by Bifidobacterium spp</title> <source>Int J Food Microbiol</source> <year>1994</year> <volume>24</volume> <fpage>199</fpage> - <lpage>210</lpage>
<author><surname>Salyers</surname> <given-names>AA</given-names></author> <author><surname>Vercellotti</surname> <given-names>JR</given-names></author> <author><surname>West</surname> <given-names>SEH</given-names></author> <author><surname>Wilkins</surname> <given-names>TD</given-names></author> <title>Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon</title> <source>Appl Environ Microbiol</source> <year>1977</year> <volume>33</volume> <fpage>319</fpage> - <lpage>322</lpage>
<author><surname>Kajinuma</surname> <given-names>H</given-names></author> <author><surname>Kuzuya</surname> <given-names>T</given-names></author> <author><surname>Ide</surname> <given-names>T</given-names></author> <author><surname>Tyler</surname> <given-names>JM</given-names></author> <title>Effects of glucosamine on insulin and glucagon secretion in dogs and ducks</title> <source>Endocrinol Jpn</source> <year>1975</year> <volume>22</volume> <fpage>517</fpage> - <lpage>523</lpage>
<author><surname>Giaccari</surname> <given-names>A</given-names></author> <author><surname>Morviducci</surname> <given-names>L</given-names></author> <author><surname>Zorretta</surname> <given-names>D</given-names></author> <title>In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia</title> <source>Diabetologia</source> <year>1995</year> <volume>38</volume> <fpage>518</fpage> - <lpage>524</lpage>
<author><surname>Baron</surname> <given-names>AD</given-names></author> <author><surname>Zhu</surname> <given-names>J-S</given-names></author> <author><surname>Zhu</surname> <given-names>J-H</given-names></author> <author><surname>Weldon</surname> <given-names>H</given-names></author> <author><surname>Maianu</surname> <given-names>L</given-names></author> <author><surname>Garvey</surname> <given-names>WT</given-names></author> <title>Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity</title> <source>J Clin Invest</source> <year>1995</year> <volume>96</volume> <fpage>2792</fpage> - <lpage>2801</lpage>
<author><surname>Rossetti</surname> <given-names>L</given-names></author> <author><surname>Hawkins</surname> <given-names>M</given-names></author> <author><surname>Chen</surname> <given-names>W</given-names></author> <author><surname>Gindi</surname> <given-names>J</given-names></author> <author><surname>Barzilai</surname> <given-names>N</given-names></author> <title>In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats</title> <source>J Clin Invest</source> <year>1995</year> <volume>96</volume> <fpage>132</fpage> - <lpage>140</lpage>
<author><surname>Hawkins</surname> <given-names>M</given-names></author> <author><surname>Angelov</surname> <given-names>I</given-names></author> <author><surname>Liu</surname> <given-names>R</given-names></author> <author><surname>Barzilai</surname> <given-names>N</given-names></author> <author><surname>Rossetti</surname> <given-names>L</given-names></author> <title>The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake</title> <source>J Biol Chem</source> <year>1997</year> <volume>272</volume> <fpage>4889</fpage> - <lpage>4895</lpage>
<author><surname>Virkam&#228;ki</surname> <given-names>A</given-names></author> <author><surname>Daniels</surname> <given-names>MC</given-names></author> <author><surname>H&#228;mal&#228;inen</surname> <given-names>S</given-names></author> <author><surname>Utriainen</surname> <given-names>T</given-names></author> <author><surname>McClain</surname> <given-names>D</given-names></author> <author><surname>Yki-J&#228;rvinen</surname> <given-names>H</given-names></author> <title>Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues</title> <source>Endocrinology</source> <year>1997</year> <volume>138</volume> <fpage>2501</fpage> - <lpage>2507</lpage>
<author><surname>Holm&#228;ng</surname> <given-names>A</given-names></author> <author><surname>Nilsson</surname> <given-names>C</given-names></author> <author><surname>Niklasson</surname> <given-names>M</given-names></author> <author><surname>Larsson</surname> <given-names>BM</given-names></author> <author><surname>Lonroth</surname> <given-names>P</given-names></author> <title>Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin</title> <source>Diabetes</source> <year>1999</year> <volume>48</volume> <fpage>106</fpage> - <lpage>111</lpage>
<author><surname>Kim</surname> <given-names>YB</given-names></author> <author><surname>Zhu</surname> <given-names>JS</given-names></author> <author><surname>Zierath</surname> <given-names>JR</given-names></author> <author><surname>Shen</surname> <given-names>HQ</given-names></author> <author><surname>Baron</surname> <given-names>AD</given-names></author> <author><surname>Kahn</surname> <given-names>BB</given-names></author> <title>Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle</title> <source>Diabetes</source> <year>1999</year> <volume>48</volume> <fpage>310</fpage> - <lpage>320</lpage>
<author><surname>Patti</surname> <given-names>ME</given-names></author> <author><surname>Virkamaki</surname> <given-names>A</given-names></author> <author><surname>Landaker</surname> <given-names>EJ</given-names></author> <author><surname>Kahn</surname> <given-names>CR</given-names></author> <author><surname>Yki-Jarvinen</surname> <given-names>H</given-names></author> <title>Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle</title> <source>Diabetes</source> <year>1999</year> <volume>48</volume> <fpage>1562</fpage> - <lpage>1571</lpage>
<author><surname>Spampinato</surname> <given-names>D</given-names></author> <author><surname>Giaccari</surname> <given-names>A</given-names></author> <author><surname>Trischitta</surname> <given-names>V</given-names></author> <title>Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation</title> <source>Metabolism</source> <year>2003</year> <volume>52</volume> <fpage>1092</fpage> - <lpage>1095</lpage>
<author><surname>Robertson</surname> <given-names>MW</given-names></author> <author><surname>Dunshea</surname> <given-names>FR</given-names></author> <author><surname>Goddard</surname> <given-names>ME</given-names></author> <author><surname>Leury</surname> <given-names>BJ</given-names></author> <title>Stimulation of the hexosamine biosynthetic pathway by glucosamine in sheep</title> <source>Asia Pac J Clin Nutr</source> <year>2005</year> <volume>14</volume> <issue>suppl</issue> <fpage>S79</fpage>
<author><surname>Monauni</surname> <given-names>T</given-names></author> <author><surname>Zenti</surname> <given-names>MG</given-names></author> <author><surname>Cretti</surname> <given-names>A</given-names></author> <title>Effects of glucosamine infusion on insulin secretion and insulin action in humans</title> <source>Diabetes</source> <year>2000</year> <volume>49</volume> <fpage>926</fpage> - <lpage>935</lpage>
<author><surname>Pouwels</surname> <given-names>M-J</given-names></author> <author><surname>Jacobs</surname> <given-names>JR</given-names></author> <author><surname>Span</surname> <given-names>PN</given-names></author> <author><surname>Lutterman</surname> <given-names>JA</given-names></author> <author><surname>Smits</surname> <given-names>P</given-names></author> <author><surname>Tack</surname> <given-names>CJ</given-names></author> <title>Short-term glucosamine infusion does not affect insulin sensitivity in humans</title> <source>J Clin Endocrinol Metab</source> <year>2001</year> <volume>86</volume> <fpage>2099</fpage> - <lpage>2103</lpage>
<author><surname>Oguchi</surname> <given-names>M</given-names></author> <author><surname>Miyatake</surname> <given-names>Y</given-names></author> <author><surname>Ayabe</surname> <given-names>J</given-names></author> <author><surname>Akamatsu</surname> <given-names>N</given-names></author> <title>Phosphorylation of D-glucosamine by rat liver glucokinase</title> <source>J Biochem</source> <year>1975</year> <volume>77</volume> <fpage>1117</fpage> - <lpage>1121</lpage>
<author><surname>Agius</surname> <given-names>L</given-names></author> <author><surname>Stubbs</surname> <given-names>M</given-names></author> <title>Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites</title> <source>Biochem J</source> <year>2000</year> <volume>346</volume> <fpage>413</fpage> - <lpage>421</lpage>
<author><surname>Albert</surname> <given-names>SG</given-names></author> <author><surname>Oiknine</surname> <given-names>RF</given-names></author> <author><surname>Parseghian</surname> <given-names>S</given-names></author> <author><surname>Mooradian</surname> <given-names>AD</given-names></author> <author><surname>Haas</surname> <given-names>MJ</given-names></author> <author><surname>McPherson</surname> <given-names>T</given-names></author> <title>The effect of glucosamine on serum HDL cholesterol and apolipoprotein AI levels in people with diabetes</title> <source>Diabetes Care</source> <year>2007</year> <volume>30</volume> <fpage>2800</fpage> - <lpage>2803</lpage>
<author><surname>Yu</surname> <given-names>JG</given-names></author> <author><surname>Boies</surname> <given-names>SM</given-names></author> <author><surname>Olefsky</surname> <given-names>JM</given-names></author> <title>The effect of oral glucosamine sulfate on insulin sensitivity in human subjects</title> <source>Diabetes Care</source> <year>2003</year> <volume>26</volume> <fpage>1941</fpage> - <lpage>1942</lpage>
<author><surname>Scroggie</surname> <given-names>DA</given-names></author> <author><surname>Albright</surname> <given-names>A</given-names></author> <author><surname>Harris</surname> <given-names>MD</given-names></author> <title>The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial</title> <source>Arch Intern Med</source> <year>2003</year> <volume>163</volume> <fpage>1587</fpage> - <lpage>1590</lpage>
<author><surname>Tapadinhas</surname> <given-names>MJ</given-names></author> <author><surname>Rivera</surname> <given-names>IC</given-names></author> <author><surname>Bignamini</surname> <given-names>AA</given-names></author> <title>Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal</title> <source>Pharmatherapeutica</source> <year>1982</year> <volume>3</volume> <fpage>157</fpage> - <lpage>168</lpage>
<author><surname>Clegg</surname> <given-names>DO</given-names></author> <author><surname>Reda</surname> <given-names>DJ</given-names></author> <author><surname>Harris</surname> <given-names>CL</given-names></author> <title>Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis</title> <source>N Engl J Med</source> <year>2006</year> <volume>354</volume> <fpage>795</fpage> - <lpage>808</lpage>
<author><surname>Tannis</surname> <given-names>AJ</given-names></author> <author><surname>Barban</surname> <given-names>J</given-names></author> <author><surname>Conquer</surname> <given-names>JA</given-names></author> <title>Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals</title> <source>Osteoarthritis Cartilage</source> <year>2004</year> <volume>12</volume> <fpage>506</fpage> - <lpage>511</lpage>
<author><surname>Hughes</surname> <given-names>R</given-names></author> <author><surname>Carr</surname> <given-names>A</given-names></author> <title>A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee</title> <source>Rheumatology</source> <year>2002</year> <volume>41</volume> <fpage>279</fpage> - <lpage>284</lpage>
<author><surname>Pavelk&#225</surname>; <given-names>K</given-names></author> <author><surname>Gatterova</surname> <given-names>J</given-names></author> <author><surname>Olejarova</surname> <given-names>M</given-names></author> <author><surname>Machacek</surname> <given-names>S</given-names></author> <author><surname>Giacovelli</surname> <given-names>G</given-names></author> <author><surname>Rovati</surname> <given-names>LC</given-names></author> <title>Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study</title> <source>Arch Intern Med</source> <year>2002</year> <volume>162</volume> <fpage>2113</fpage> - <lpage>2123</lpage>
<author><surname>Reginster</surname> <given-names>JY</given-names></author> <author><surname>Deroisy</surname> <given-names>R</given-names></author> <author><surname>Rovati</surname> <given-names>LC</given-names></author> <title>Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial</title> <source>Lancet</source> <year>2001</year> <volume>357</volume> <fpage>251</fpage> - <lpage>256</lpage>
<author><surname>Almada</surname> <given-names>AL</given-names></author> <author><surname>Harvey</surname> <given-names>P</given-names></author> <author><surname>Platt</surname> <given-names>K</given-names></author> <title>Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in non-diabetic individuals</title> <source>FASEB J</source> <year>2000</year> <volume>14</volume> <fpage>A750</fpage> [Abstract 521.15]
<author><surname>Giordano</surname> <given-names>N</given-names></author> <author><surname>Nardi</surname> <given-names>P</given-names></author> <author><surname>Senesi</surname> <given-names>M</given-names></author> <title>Efficacia e tollerabilit&#224; della glucosamina solfato nel trattamento della gonartrosi. [The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis</title>] <source>Clin Ter</source> <year>1996</year> <volume>147</volume> <fpage>99</fpage> - <lpage>105</lpage>
<author><surname>Noack</surname> <given-names>W</given-names></author> <author><surname>Fischer</surname> <given-names>M</given-names></author> <author><surname>Forster</surname> <given-names>KK</given-names></author> <author><surname>Rovati</surname> <given-names>LC</given-names></author> <author><surname>Setnikar</surname> <given-names>I</given-names></author> <title>Glucosamine sulfate in osteoarthritis of the knee</title> <source>Osteoarthritis Cartilage</source> <year>1994</year> <volume>2</volume> <fpage>51</fpage> - <lpage>59</lpage>
<author><surname>D"Ambrosio</surname> <given-names>E</given-names></author> <author><surname>Casa</surname> <given-names>B</given-names></author> <author><surname>Bompani</surname> <given-names>R</given-names></author> <author><surname>Scali</surname> <given-names>G</given-names></author> <author><surname>Scali</surname> <given-names>M</given-names></author> <title>Glucosamine sulphate: a controlled clinical investigation in arthrosis</title> <source>Pharmatherapeutica</source> <year>1981</year> <volume>2</volume> <fpage>504</fpage> - <lpage>508</lpage>
<author><surname>Drovanti</surname> <given-names>A</given-names></author> <author><surname>Bignamini</surname> <given-names>AA</given-names></author> <author><surname>Rovati</surname> <given-names>AL</given-names></author> <title>Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation</title> <source>Clin Ther</source> <year>1980</year> <volume>3</volume> <fpage>260</fpage> - <lpage>272</lpage>
<author><surname>Crolle</surname> <given-names>G</given-names></author> <author><surname>D"Este</surname> <given-names>E</given-names></author> <title>Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation</title> <source>Curr Med Res Opin</source> <year>1980</year> <volume>7</volume> <fpage>104</fpage> - <lpage>109</lpage>
<author><surname>Laferr&#232;re</surname> <given-names>B</given-names></author> <author><surname>Garcia-Lorda</surname> <given-names>P</given-names></author> <author><surname>Russell</surname> <given-names>CD</given-names></author> <author><surname>Pi-Sunyer</surname> <given-names>FX</given-names></author> <title>Effect of oral glucosamine sulfate on serum leptin levels in human subjects</title> <source>Nutrition</source> <year>2004</year> <volume>20</volume> <fpage>321</fpage> - <lpage>322</lpage>
<author><surname>Pujalte</surname> <given-names>JM</given-names></author> <author><surname>Llavore</surname> <given-names>EP</given-names></author> <author><surname>Ylescupidez</surname> <given-names>FR</given-names></author> <title>Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis</title> <source>Curr Med Res Opin</source> <year>1980</year> <volume>7</volume> <fpage>110</fpage> - <lpage>114</lpage>
<author><surname>Rovati</surname> <given-names>LC</given-names></author> <title>Clinical research in osteoarthritis: design and results of short-term and long-term with disease-modifying drugs</title> <source>Int J Tissue React</source> <year>1992</year> <volume>14</volume> <fpage>243</fpage> - <lpage>251</lpage>
<author><surname>Qiu</surname> <given-names>GX</given-names></author> <author><surname>Gao</surname> <given-names>SN</given-names></author> <author><surname>Giacovelli</surname> <given-names>G</given-names></author> <author><surname>Rovati</surname> <given-names>L</given-names></author> <author><surname>Setnikar</surname> <given-names>I</given-names></author> <title>Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis</title> <source>Arzneimittelforschung</source> <year>1998</year> <volume>48</volume> <fpage>469</fpage> - <lpage>474</lpage>
<author><surname>Valensi</surname> <given-names>P</given-names></author> <author><surname>Schwarz</surname> <given-names>EH</given-names></author> <author><surname>Hall</surname> <given-names>M</given-names></author> <author><surname>Felton</surname> <given-names>AM</given-names></author> <author><surname>Maldonato</surname> <given-names>A</given-names></author> <author><surname>Mathieu</surname> <given-names>C</given-names></author> <title>Pre-diabetes essential action: a European perspective</title> <source>Diabetes Metab</source> <year>2005</year> <volume>31</volume> <fpage>606</fpage> - <lpage>620</lpage>
<title>IDF Prevalence estimates of diabetes mellitus (DM), 2010</title> <source>Diabetes Atlas: The e-Atlas</source> <year>2010</year> <issue>4th edn</issue> <other>Brussels, Belgium</other> <publisher>The International Diabetes Federation (IDF) Available</publisher> at:
<source>EC Population Statistics: Detailed Tables</source> <year>2004</year> <source>Luxembourg Office for Official Publications of the European Communities</source> <publisher>Available at</publisher>
<author><surname>Lee</surname> <given-names>YH</given-names></author> <author><surname>Woo</surname> <given-names>JH</given-names></author> <author><surname>Choi</surname> <given-names>SJ</given-names></author> <author><surname>Ji</surname> <given-names>JD</given-names></author> <author><surname>Song</surname> <given-names>GG</given-names></author> <title>Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis</title> <source>Rheumatol Int</source> <year>2010</year> <volume>30</volume> <fpage>357</fpage> - <lpage>363</lpage>
<author><surname>Marshall</surname> <given-names>S</given-names></author> <author><surname>Nadeau</surname> <given-names>O</given-names></author> <author><surname>Yamasaki</surname> <given-names>K</given-names></author> <title>Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels</title> <source>J Biol Chem</source> <year>2004</year> <volume>279</volume> <fpage>35313</fpage> - <lpage>35319</lpage>
<author><surname>Heart</surname> <given-names>E</given-names></author> <author><surname>Choi</surname> <given-names>WS</given-names></author> <author><surname>Sung</surname> <given-names>CK</given-names></author> <title>Glucosamine-induced insulin resistance in 3T3-L1 adipocytes</title> <source>Am J Physiol Endocrinol Metab</source> <year>2000</year> <volume>278</volume> <fpage>E103</fpage> - <lpage>112</lpage>
<author><surname>Echard</surname> <given-names>BW</given-names></author> <author><surname>Talpur</surname> <given-names>NA</given-names></author> <author><surname>Funk</surname> <given-names>KA</given-names></author> <author><surname>Bagchi</surname> <given-names>D</given-names></author> <author><surname>Preuss</surname> <given-names>HG</given-names></author> <title>Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats</title> <source>Mol Cell Biochem</source> <year>2001</year> <volume>225</volume> <fpage>85</fpage> - <lpage>91</lpage>
<author><surname>McNamara</surname> <given-names>PS</given-names></author> <author><surname>Barr</surname> <given-names>SC</given-names></author> <author><surname>Erb</surname> <given-names>HN</given-names></author> <title>Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days</title> <source>Am J Vet Res</source> <year>1996</year> <volume>57</volume> <fpage>1390</fpage> - <lpage>1394</lpage>
<author><surname>Stender</surname> <given-names>S</given-names></author> <author><surname>Astrup</surname> <given-names>P</given-names></author> <title>Glucosamine and experimental atherosclerosis. Increased wet weight and charged composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine</title> <source>Atherosclerosis</source> <year>1977</year> <volume>26</volume> <fpage>205</fpage> - <lpage>213</lpage>
<author><surname>Cryer</surname> <given-names>PE</given-names></author> <title>The barrier of hypoglycemia in diabetes</title> <source>Diabetes</source> <year>2008</year> <volume>57</volume> <fpage>3169</fpage> - <lpage>3176</lpage>
<author><surname>Dagogo-Jack</surname> <given-names>SE</given-names></author> <author><surname>Craft</surname> <given-names>S</given-names></author> <author><surname>Cryer</surname> <given-names>PE</given-names></author> <title>Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia</title> <source>J Clin Invest</source> <year>1993</year> <volume>91</volume> <fpage>819</fpage> - <lpage>828</lpage>
<author><surname>Cryer</surname> <given-names>PE</given-names></author> <title>Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes</title> <source>Diabetologia</source> <year>2002</year> <volume>45</volume> <fpage>937</fpage> - <lpage>948</lpage>
<author><surname>Davis</surname> <given-names>MR</given-names></author> <author><surname>Shamoon</surname> <given-names>H</given-names></author> <title>Counterregulatory adaptation to recurrent hypoglycemia in normal humans</title> <source>J Clin Endocrinol Metab</source> <year>1991</year> <volume>73</volume> <fpage>995</fpage> - <lpage>1001</lpage>
<author><surname>Davis</surname> <given-names>SN</given-names></author> <author><surname>Mann</surname> <given-names>S</given-names></author> <author><surname>Galassetti</surname> <given-names>P</given-names></author> <title>Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans</title> <source>Diabetes</source> <year>2000</year> <volume>49</volume> <fpage>1897</fpage> - <lpage>1903</lpage>
<author><surname>Heller</surname> <given-names>SR</given-names></author> <author><surname>Cryer</surname> <given-names>PE</given-names></author> <title>Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans</title> <source>Diabetes</source> <year>1991</year> <volume>40</volume> <fpage>223</fpage> - <lpage>226</lpage>
<author><surname>Geddes</surname> <given-names>J</given-names></author> <author><surname>Wright</surname> <given-names>RJ</given-names></author> <author><surname>Zammitt</surname> <given-names>NN</given-names></author> <author><surname>Deary</surname> <given-names>IJ</given-names></author> <author><surname>Frier</surname> <given-names>BM</given-names></author> <title>An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes</title> <source>Diab Care</source> <year>2007</year> <volume>30</volume> <fpage>1868</fpage> - <lpage>1870</lpage>
<author><surname>Pedersen-Bjergaard</surname> <given-names>U</given-names></author> <author><surname>Agerholm-Larsen</surname> <given-names>B</given-names></author> <author><surname>Pramming</surname> <given-names>S</given-names></author> <author><surname>Hougaard</surname> <given-names>P</given-names></author> <author><surname>Thorsteinsson</surname> <given-names>B</given-names></author> <title>Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus</title> <source>Lancet</source> <year>2001</year> <volume>357</volume> <fpage>1248</fpage> - <lpage>1253</lpage>
<author><surname>Pedersen-Bjergaard</surname> <given-names>U</given-names></author> <author><surname>Dhamrait</surname> <given-names>SS</given-names></author> <author><surname>Sethi</surname> <given-names>AA</given-names></author> <title>Genetic variation and activity of the renin&#8211;angiotensin system and severe hypoglycemia in type 1 diabetes</title> <source>Am J Med</source> <year>2008</year> <volume>121</volume> <fpage>246</fpage> - <lpage>248</lpage>
<author><surname>Schouwenberg</surname> <given-names>BJ</given-names></author> <author><surname>Veldman</surname> <given-names>BA</given-names></author> <author><surname>Spiering</surname> <given-names>W</given-names></author> <title>The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus</title> <source>Pharmacogenet Genomics</source> <year>2008</year> <volume>18</volume> <fpage>369</fpage> - <lpage>372</lpage>
<author><surname>Leineweber</surname> <given-names>K</given-names></author> <author><surname>Brodde</surname> <given-names>OE</given-names></author> <title>Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes</title> <source>Life Sci</source> <year>2004</year> <volume>74</volume> <fpage>2803</fpage> - <lpage>2814</lpage>
<author><surname>Green</surname> <given-names>SA</given-names></author> <author><surname>Turki</surname> <given-names>J</given-names></author> <author><surname>Innis</surname> <given-names>M</given-names></author> <author><surname>Liggett</surname> <given-names>SB</given-names></author> <title>Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties</title> <source>Biochemistry</source> <year>1994</year> <volume>33</volume> <fpage>9414</fpage> - <lpage>9419</lpage>
<author><surname>Liggett</surname> <given-names>SB</given-names></author> <title>beta (2)-adrenergic receptor pharmacogenetics</title> <source>Am J Respir Crit Care Med</source> <year>2000</year> <volume>161</volume> <fpage>S197</fpage> - <lpage>201</lpage>
<author><surname>Korytkowski</surname> <given-names>MT</given-names></author> <author><surname>Mokan</surname> <given-names>M</given-names></author> <author><surname>Veneman</surname> <given-names>TF</given-names></author> <author><surname>Mitrakou</surname> <given-names>A</given-names></author> <author><surname>Cryer</surname> <given-names>PE</given-names></author> <author><surname>Gerich</surname> <given-names>JE</given-names></author> <title>Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness</title> <source>Diab Care</source> <year>1998</year> <volume>21</volume> <fpage>1939</fpage> - <lpage>1943</lpage>
<author><surname>Fritsche</surname> <given-names>A</given-names></author> <author><surname>Stumvoll</surname> <given-names>M</given-names></author> <author><surname>Grub</surname> <given-names>M</given-names></author> <title>Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects</title> <source>Diab Care</source> <year>1998</year> <volume>21</volume> <fpage>1505</fpage> - <lpage>1510</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names></author> <author><surname>Grimaldi</surname> <given-names>A</given-names></author> <author><surname>Payan</surname> <given-names>C</given-names></author> <title>Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients</title> <source>Diab Care</source> <year>1987</year> <volume>10</volume> <fpage>742</fpage> - <lpage>747</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names></author> <author><surname>Grimaldi</surname> <given-names>A</given-names></author> <author><surname>Bosquet</surname> <given-names>F</given-names></author> <author><surname>Puech</surname> <given-names>AJ</given-names></author> <title>Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects</title> <source>J Clin Endocrinol Metab</source> <year>1986</year> <volume>63</volume> <fpage>262</fpage> - <lpage>265</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names></author> <author><surname>Jaeger</surname> <given-names>R</given-names></author> <author><surname>Jorde</surname> <given-names>R</given-names></author> <author><surname>Sager</surname> <given-names>G</given-names></author> <title>Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness</title> <source>Br J Clin Pharmacol</source> <year>1994</year> <volume>38</volume> <fpage>427</fpage> - <lpage>432</lpage>
<author><surname>Schwab</surname> <given-names>KO</given-names></author> <author><surname>Menche</surname> <given-names>U</given-names></author> <author><surname>Schmeisl</surname> <given-names>G</given-names></author> <author><surname>Lohse</surname> <given-names>MJ</given-names></author> <title>Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type-1 diabetes</title>? <source>Horm Res</source> <year>2004</year> <volume>62</volume> <fpage>137</fpage> - <lpage>141</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names></author> <author><surname>Vaartun</surname> <given-names>A</given-names></author> <author><surname>Jorde</surname> <given-names>R</given-names></author> <author><surname>Sager</surname> <given-names>G</given-names></author> <title>Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia</title> <source>Eur J Clin Pharmacol</source> <year>1995</year> <volume>48</volume> <fpage>327</fpage> - <lpage>332</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names></author> <author><surname>Jaeger</surname> <given-names>R</given-names></author> <author><surname>Jorde</surname> <given-names>R</given-names></author> <author><surname>Sager</surname> <given-names>G</given-names></author> <title>Reduced beta-adrenergic sensitivity in healthy participants induced by hypoglycemia</title> <source>Fundam Clin Pharmacol</source> <year>1995</year> <volume>9</volume> <fpage>181</fpage> - <lpage>186</lpage>
<author><surname>Liu</surname> <given-names>D</given-names></author> <author><surname>Moberg</surname> <given-names>E</given-names></author> <author><surname>Kollind</surname> <given-names>M</given-names></author> <author><surname>Lins</surname> <given-names>PE</given-names></author> <author><surname>Adamson</surname> <given-names>U</given-names></author> <author><surname>MacDonald</surname> <given-names>IA</given-names></author> <title>Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia</title> <source>Diabetologia</source> <year>1992</year> <volume>35</volume> <fpage>287</fpage> - <lpage>290</lpage>
<author><surname>Deary</surname> <given-names>IJ</given-names></author> <author><surname>Hepburn</surname> <given-names>DA</given-names></author> <author><surname>MacLeod</surname> <given-names>KM</given-names></author> <author><surname>Frier</surname> <given-names>BM</given-names></author> <title>Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis</title> <source>Diabetologia</source> <year>1993</year> <volume>36</volume> <fpage>771</fpage> - <lpage>777</lpage>
<author><surname>Galan</surname> <given-names>BE</given-names></author> <author><surname>Mol</surname> <given-names>P</given-names></author> <author><surname>Wennekes</surname> <given-names>L</given-names></author> <author><surname>Schouwenberg</surname> <given-names>BJ</given-names></author> <author><surname>Smits</surname> <given-names>P</given-names></author> <title>Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness</title> <source>J Clin Endocrinol Metab</source> <year>2006</year> <volume>91</volume> <fpage>2878</fpage> - <lpage>2881</lpage>
<author><surname>Meijer</surname> <given-names>P</given-names></author> <author><surname>Wouters</surname> <given-names>CW</given-names></author> <author><surname>Broek</surname> <given-names>PH</given-names></author> <title>Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation</title> <source>Br J Pharmacol</source> <year>2008</year> <volume>153</volume> <fpage>1169</fpage> - <lpage>1176</lpage>
<author><surname>Lenders</surname> <given-names>J</given-names></author> <author><surname>Janssen</surname> <given-names>GJ</given-names></author> <author><surname>Smits</surname> <given-names>P</given-names></author> <author><surname>Thien</surname> <given-names>T</given-names></author> <title>Role of the wrist cuff in forearm plethysmography</title> <source>Clin Sci (Lond)</source> <year>1991</year> <volume>80</volume> <fpage>413</fpage> - <lpage>417</lpage>
<author><surname>Cleaveland</surname> <given-names>CR</given-names></author> <author><surname>Rangno</surname> <given-names>RE</given-names></author> <author><surname>Shand</surname> <given-names>DG</given-names></author> <title>A standardized isoproteranol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol</title> <source>Arch Intern Med</source> <year>1972</year> <volume>130</volume> <fpage>47</fpage> - <lpage>52</lpage>
<author><surname>Miller</surname> <given-names>SA</given-names></author> <author><surname>Dykes</surname> <given-names>DD</given-names></author> <author><surname>Polesky</surname> <given-names>HF</given-names></author> <title>A simple salting out procedure for extracting DNA from human nucleated cells</title> <source>Nucleic Acids Res</source> <year>1988</year> <volume>16</volume> <fpage>1215</fpage>
<author><surname>Ronaghi</surname> <given-names>M</given-names></author> <title>Pyrosequencing for SNP genotyping</title> <source>Methods Mol Biol</source> <year>2003</year> <volume>212</volume> <fpage>189</fpage> - <lpage>195</lpage>
<author><surname>Willemsen</surname> <given-names>JJ</given-names></author> <author><surname>Ross</surname> <given-names>HA</given-names></author> <author><surname>Jacobs</surname> <given-names>MC</given-names></author> <title>Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans</title> <source>Clin Chem</source> <year>1995</year> <volume>41</volume> <fpage>1455</fpage> - <lpage>1460</lpage>
<author><surname>Galan</surname> <given-names>BE</given-names></author> <author><surname>Tack</surname> <given-names>CJ</given-names></author> <author><surname>Lenders</surname> <given-names>JW</given-names></author> <title>Theophylline improves hypoglycemia unawareness in type 1 diabetes</title> <source>Diabetes</source> <year>2002</year> <volume>51</volume> <fpage>790</fpage> - <lpage>796</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names></author> <author><surname>Grimaldi</surname> <given-names>A</given-names></author> <author><surname>Landault</surname> <given-names>C</given-names></author> <title>Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients</title> <source>J Clin Endocrinol Metab</source> <year>1988</year> <volume>66</volume> <fpage>273</fpage> - <lpage>278</lpage>
<author><surname>Macmillan</surname> <given-names>AK</given-names></author> <author><surname>Merrie</surname> <given-names>AE</given-names></author> <author><surname>Marshall</surname> <given-names>RJ</given-names></author> <author><surname>Parry</surname> <given-names>BR</given-names></author> <title>The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature</title> <source>Dis Colon Rectum</source> <year>2004</year> <volume>47</volume> <fpage>1341</fpage> - <lpage>1349</lpage>
<author><surname>Shafik</surname> <given-names>A</given-names></author> <title>Polytetrafluoroethylene injection for the treatment of partial fecal incontinence</title> <source>Int Surg</source> <year>1993</year> <volume>78</volume> <fpage>159</fpage> - <lpage>161</lpage>
<author><surname>Kumar</surname> <given-names>D</given-names></author> <author><surname>Benson</surname> <given-names>MJ</given-names></author> <author><surname>Bland</surname> <given-names>JE</given-names></author> <title>Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence</title> <source>Br J Surg</source> <year>1998</year> <volume>85</volume> <fpage>978</fpage> - <lpage>979</lpage>
<author><surname>Shafik</surname> <given-names>A</given-names></author> <title>Perianal injection of autologous fat for treatment of sphincteric incontinence</title> <source>Dis Colon Rectum</source> <year>1995</year> <volume>38</volume> <fpage>583</fpage> - <lpage>587</lpage>
<author><surname>Malouf</surname> <given-names>AJ</given-names></author> <author><surname>Vaizey</surname> <given-names>CJ</given-names></author> <author><surname>Norton</surname> <given-names>CS</given-names></author> <author><surname>Kamm</surname> <given-names>MA</given-names></author> <title>Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial</title> <source>Dis Colon Rectum</source> <year>2001</year> <volume>44</volume> <fpage>595</fpage> - <lpage>600</lpage>
<author><surname>Chan</surname> <given-names>MK</given-names></author> <author><surname>Tjandra</surname> <given-names>JJ</given-names></author> <title>Injectable silicone biomaterial (PTQ) to treat fecal incontinence after hemorrhoidectomy</title> <source>Dis Colon Rectum</source> <year>2006</year> <volume>49</volume> <fpage>433</fpage> - <lpage>439</lpage>
<author><surname>Tjandra</surname> <given-names>JJ</given-names></author> <author><surname>Lim</surname> <given-names>JF</given-names></author> <author><surname>Hiscock</surname> <given-names>R</given-names></author> <author><surname>Rajendra</surname> <given-names>P</given-names></author> <title>Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective</title> <source>Dis Colon Rectum</source> <year>2004</year> <volume>47</volume> <fpage>2138</fpage> - <lpage>2146</lpage>
<author><surname>Kenefick</surname> <given-names>NJ</given-names></author> <author><surname>Vaizey</surname> <given-names>CJ</given-names></author> <author><surname>Malouf</surname> <given-names>AJ</given-names></author> <author><surname>Norton</surname> <given-names>CS</given-names></author> <author><surname>Marshall</surname> <given-names>M</given-names></author> <author><surname>Kamm</surname> <given-names>MA</given-names></author> <title>Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction</title> <source>Gut</source> <year>2002</year> <volume>51</volume> <fpage>225</fpage> - <lpage>228</lpage>
<author><surname>Davis</surname> <given-names>K</given-names></author> <author><surname>Kumar</surname> <given-names>D</given-names></author> <author><surname>Poloniecki</surname> <given-names>J</given-names></author> <title>Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence</title> <source>Aliment Pharmacol Ther</source> <year>2003</year> <volume>18</volume> <fpage>237</fpage> - <lpage>243</lpage>
<author><surname>Pannek</surname> <given-names>J</given-names></author> <author><surname>Brands</surname> <given-names>FH</given-names></author> <author><surname>Senge</surname> <given-names>T</given-names></author> <title>Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence</title> <source>J Urol</source> <year>2001</year> <volume>166</volume> <fpage>1350</fpage> - <lpage>1353</lpage>
<author><surname>Emans</surname> <given-names>PJ</given-names></author> <author><surname>Saralidze</surname> <given-names>K</given-names></author> <author><surname>Knetsch</surname> <given-names>ML</given-names></author> <author><surname>Gijbels</surname> <given-names>MJ</given-names></author> <author><surname>Kuijer</surname> <given-names>R</given-names></author> <author><surname>Koole</surname> <given-names>LH</given-names></author> <title>Development of new injectable bulking agents: biocompatibility of radiopaque polymeric microspheres studied in a mouse model</title> <source>J Biomed Mater Res A</source> <year>2005</year> <volume>73</volume> <fpage>430</fpage> - <lpage>436</lpage>
<author><surname>Kuang</surname> <given-names>S</given-names></author> <author><surname>Kuroda</surname> <given-names>K</given-names></author> <author><surname>Grand</surname> <given-names>F</given-names></author> <author><surname>Rudnicki</surname> <given-names>MA</given-names></author> <title>Asymmetric self-renewal and commitment of satellite stem cells in muscle</title> <source>Cell</source> <year>2007</year> <volume>129</volume> <fpage>999</fpage> - <lpage>1010</lpage>
<author><surname>Qu-Petersen</surname> <given-names>Z</given-names></author> <author><surname>Deasy</surname> <given-names>B</given-names></author> <author><surname>Jankowski</surname> <given-names>R</given-names></author> <title>Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration</title> <source>J Cell Biol</source> <year>2002</year> <volume>157</volume> <fpage>851</fpage> - <lpage>864</lpage>
<author><surname>Lee</surname> <given-names>JY</given-names></author> <author><surname>Paik</surname> <given-names>SY</given-names></author> <author><surname>Yuk</surname> <given-names>SH</given-names></author> <author><surname>Lee</surname> <given-names>JH</given-names></author> <author><surname>Ghil</surname> <given-names>SH</given-names></author> <author><surname>Lee</surname> <given-names>SS</given-names></author> <title>Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves</title> <source>Mol Cells</source> <year>2004</year> <volume>18</volume> <fpage>309</fpage> - <lpage>313</lpage>
<author><surname>Cannon</surname> <given-names>TW</given-names></author> <author><surname>Lee</surname> <given-names>JY</given-names></author> <author><surname>Somogyi</surname> <given-names>G</given-names></author> <title>Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra</title> <source>Urology</source> <year>2003</year> <volume>62</volume> <fpage>958</fpage> - <lpage>963</lpage>
<author><surname>Yiou</surname> <given-names>R</given-names></author> <author><surname>Yoo</surname> <given-names>JJ</given-names></author> <author><surname>Atala</surname> <given-names>A</given-names></author> <title>Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts</title> <source>Transplantation</source> <year>2003</year> <volume>76</volume> <fpage>1053</fpage> - <lpage>1060</lpage>
<author><surname>Kwon</surname> <given-names>D</given-names></author> <author><surname>Kim</surname> <given-names>Y</given-names></author> <author><surname>Pruchnic</surname> <given-names>R</given-names></author> <title>Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence</title> <source>Urology</source> <year>2006</year> <volume>68</volume> <fpage>449</fpage> - <lpage>454</lpage>
<author><surname>Lee</surname> <given-names>JY</given-names></author> <author><surname>Cannon</surname> <given-names>TW</given-names></author> <author><surname>Pruchnic</surname> <given-names>R</given-names></author> <author><surname>Fraser</surname> <given-names>MO</given-names></author> <author><surname>Huard</surname> <given-names>J</given-names></author> <author><surname>Chancellor</surname> <given-names>MB</given-names></author> <title>The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence</title> <source>Int Urogynecol J Pelvic Floor Dysfunct</source> <year>2003</year> <volume>14</volume> <fpage>31</fpage> - <lpage>37</lpage>
<author><surname>Yiou</surname> <given-names>R</given-names></author> <author><surname>Dreyfus</surname> <given-names>P</given-names></author> <author><surname>Chopin</surname> <given-names>DK</given-names></author> <author><surname>Abbou</surname> <given-names>CC</given-names></author> <author><surname>Lefaucheur</surname> <given-names>JP</given-names></author> <title>Muscle precursor cell autografting in a murine model of urethral sphincter injury</title> <source>BJU Int</source> <year>2002</year> <volume>89</volume> <fpage>298</fpage> - <lpage>302</lpage>
<author><surname>Chermansky</surname> <given-names>CJ</given-names></author> <author><surname>Tarin</surname> <given-names>T</given-names></author> <author><surname>Kwon</surname> <given-names>DD</given-names></author> <title>Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency</title> <source>Urology</source> <year>2004</year> <volume>63</volume> <fpage>780</fpage> - <lpage>785</lpage>
<author><surname>Strasser</surname> <given-names>H</given-names></author> <author><surname>Marksteiner</surname> <given-names>R</given-names></author> <author><surname>Margreiter</surname> <given-names>E</given-names></author> <title>Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial</title> <source>Lancet</source> <year>2007</year> <volume>369</volume> <fpage>2179</fpage> - <lpage>2186</lpage>
<author><surname>Garcia-Olmo</surname> <given-names>D</given-names></author> <author><surname>Garcia-Arranz</surname> <given-names>M</given-names></author> <author><surname>Garcia</surname> <given-names>LG</given-names></author> <title>Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn&#8217;s disease: a new cell-based therapy</title> <source>Int J Colorectal Dis</source> <year>2003</year> <volume>18</volume> <fpage>451</fpage> - <lpage>454</lpage>
<author><surname>Garcia-Olmo</surname> <given-names>D</given-names></author> <author><surname>Garcia-Arranz</surname> <given-names>M</given-names></author> <author><surname>Herreros</surname> <given-names>D</given-names></author> <author><surname>Pascual</surname> <given-names>I</given-names></author> <author><surname>Peiro</surname> <given-names>C</given-names></author> <author><surname>Rodriguez-Montes</surname> <given-names>JA</given-names></author> <title>A phase I clinical trial of the treatment of Crohn&#8217;s fistula by adipose mesenchymal stem cell transplantation</title> <source>Dis Colon Rectum</source> <year>2005</year> <volume>48</volume> <fpage>1416</fpage> - <lpage>1423</lpage>
<author><surname>Rando</surname> <given-names>TA</given-names></author> <author><surname>Blau</surname> <given-names>HM</given-names></author> <title>Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy</title> <source>J Cell Biol</source> <year>1994</year> <volume>125</volume> <fpage>1275</fpage> - <lpage>1287</lpage>
<author><surname>Huard</surname> <given-names>J</given-names></author> <author><surname>Yokoyama</surname> <given-names>T</given-names></author> <author><surname>Pruchnic</surname> <given-names>R</given-names></author> <title>Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction</title> <source>Gene Ther</source> <year>2002</year> <volume>9</volume> <fpage>1617</fpage> - <lpage>1626</lpage>
<author><surname>Gulbins</surname> <given-names>H</given-names></author> <author><surname>Pritisanac</surname> <given-names>A</given-names></author> <author><surname>Anderson</surname> <given-names>I</given-names></author> <title>Myoblasts for survive 16 weeks after intracardiac transfer and start differentiation</title> <source>Thorac Cardiovasc Surg</source> <year>2003</year> <volume>51</volume> <fpage>295</fpage> - <lpage>300</lpage>
<author><surname>Hwang</surname> <given-names>JH</given-names></author> <author><surname>Yuk</surname> <given-names>SH</given-names></author> <author><surname>Lee</surname> <given-names>JH</given-names></author> <title>Isolation of muscle derived stem cells from rat and its smooth muscle differentiation</title> <source>Mol Cells</source> <year>2004</year> <volume>17</volume> <fpage>57</fpage> - <lpage>61</lpage>
<author><surname>Qu</surname> <given-names>Z</given-names></author> <author><surname>Balkir</surname> <given-names>L</given-names></author> <author><surname>Deutekom</surname> <given-names>JC</given-names></author> <author><surname>Robbins</surname> <given-names>PD</given-names></author> <author><surname>Pruchnic</surname> <given-names>R</given-names></author> <author><surname>Huard</surname> <given-names>J</given-names></author> <title>Development of approaches to improve cell survival in myoblast transfer therapy</title> <source>J Cell Biol</source> <year>1998</year> <volume>142</volume> <fpage>1257</fpage> - <lpage>1267</lpage>
<author><surname>Beauchamp</surname> <given-names>JR</given-names></author> <author><surname>Heslop</surname> <given-names>L</given-names></author> <author><surname>Yu</surname> <given-names>DS</given-names></author> <title>Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells</title> <source>J Cell Biol</source> <year>2000</year> <volume>151</volume> <fpage>1221</fpage> - <lpage>1234</lpage>
<author><surname>Yokoyama</surname> <given-names>T</given-names></author> <author><surname>Huard</surname> <given-names>J</given-names></author> <author><surname>Chancellor</surname> <given-names>MB</given-names></author> <title>Myoblast therapy for stress urinary incontinence and bladder dysfunction</title> <source>World J Urol</source> <year>2000</year> <volume>18</volume> <fpage>56</fpage> - <lpage>61</lpage>
<author><surname>Hag&#232;ge</surname> <given-names>AA</given-names></author> <author><surname>Carrion</surname> <given-names>C</given-names></author> <author><surname>Menasch&#233</surname>; <given-names>P</given-names></author> <title>Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy</title> <source>Lancet</source> <year>2003</year> <volume>361</volume> <fpage>491</fpage> - <lpage>492</lpage>
<author><surname>Alameddine</surname> <given-names>HS</given-names></author> <author><surname>Louboutin</surname> <given-names>JP</given-names></author> <author><surname>Dehaupas</surname> <given-names>M</given-names></author> <author><surname>Sebille</surname> <given-names>A</given-names></author> <author><surname>Fardeau</surname> <given-names>M</given-names></author> <title>Functional recovery induced by satellite cell grafts in irreversibly injured muscles</title> <source>Cell Transplant</source> <year>1994</year> <volume>3</volume> <fpage>3</fpage> - <lpage>14</lpage>
<author><surname>Guettier-Sigrist</surname> <given-names>S</given-names></author> <author><surname>Coupin</surname> <given-names>G</given-names></author> <author><surname>Warter</surname> <given-names>JM</given-names></author> <author><surname>Poindron</surname> <given-names>P</given-names></author> <title>Cell types required to efficiently innervate human muscle cells in vitro</title> <source>Exp Cell Res</source> <year>2000</year> <volume>259</volume> <fpage>204</fpage> - <lpage>212</lpage>
<author><surname>Alessandri</surname> <given-names>G</given-names></author> <author><surname>Pagano</surname> <given-names>S</given-names></author> <author><surname>Bez</surname> <given-names>A</given-names></author> <title>Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages</title> <source>Lancet</source> <year>2004</year> <volume>364</volume> <fpage>1872</fpage> - <lpage>1883</lpage>
